- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
- Back
On 13 May 2025, the British Healthcare Trades Association (BHTA), in coordination with AXREM, hosted a conference about the future of medtech, offering valuable and informative talks for attendees.
‘The Future of MedTech: Innovating for Tomorrow’ brought together BHTA and AXREM members to hear from senior leaders and experts from across the NHS, DHSC, MHRA, and more to explore the latest advancements and strategies in medtech.
Taking place at the Mercure Northampton, delegates had the chance to network with industry peers, get involved in engaging panel discussions, and learn about some of the most important topics in the medtech sector today.
Engaging presentations throughout the day included topics on sustainable procurement, how suppliers can meet the NHS’ net zero targets, the economic outlook for UK manufacturers, the future regulatory framework for the UK medtech sector, the DHSC’s upcoming work on building a MedTech Compass, and more.
Speakers throughout the day were:
The Future of MedTech conference has received positive feedback from attendees.
Shona Macdonald, Director of Market Access & Reimbursement, UKI, at Convatec, commented: “The BHTA and AXREM conference proved to be a highly relevant and extremely interesting agenda. It provided me with an invaluable opportunity for networking and engagement with stakeholders and peers.
“I was particularly encouraged to hear that collaboration with industry through the NHS transformative changes is both invited and welcomed by the system.”
David Dawson, Market Access Director, UK/Ireland for BD, said: “I found the BHTA conference both interesting and informative. The varied subject matter and speakers provided a good mix of important issues. I especially enjoyed the afternoon presentations and panel discussion.”
Diane Hargrove, Sales Director at BES Healthcare, stated: “I thought the quality of the speakers was excellent, and it was refreshing to hear that there seemed to be an understanding of some of the real challenges that face industry in bringing new innovative technologies through to the healthcare market.”
Richard Holland-Oakes, Co-Founder and CEO of Recare, noted: “Certain parts of the day were very interesting with the NHS and social services and the government finally trying to work together.
“I must say it appeared the presentation to be more hospital-related savings with the AXREM companies rather than the companies of BHTA and the products of which you support, NHS/community and the private sector and of which our products are bespoke to the individuals requirements, and of these products that are prescribed from the hospital environment for home use is a hard to manage and deliver a better service and savings without changing this structure that is in place at present. But it can be done!”
On 2 April 2025, the US President, Donald Trump, declared a “national emergency” and introduced wide-ranging tariffs across the world to “strengthen the international economic position of the United States and protect American workers”.
These “reciprocal tariffs” were placed on countries deemed to be giving the US a bad deal on trade, according to President Trump.
Tariffs are taxes charged on the import of goods from foreign countries. They can be used as a source of revenue for governments and to protect domestic industries from foreign competition.
In general, the importer pays the tariff, not the exporter. In the case of the new US tariffs, American companies will pay the tariffs to the US government.
President Trump stated that he has introduced these tariffs to incentivise and re-shore US manufacturing, “address the injustices of global trade”, bolster domestic jobs, and drive economic growth within the US.
A blanket 10% US reciprocal tariff was placed on countries around the world. This blanket tariff came into effect on 5 April 2025. This includes a 10% trade tariff on all imports from the UK.
60 countries faced additional, individualised, and higher reciprocal tariffs. Some of the notable higher tariffs that were set to come into effect on 9 April 2025 included China at 34%, the EU at 20%, and Taiwan at 32%.
On 9 April 2025, President Trump announced a 90-day pause for all of the countries hit by the higher US tariffs – except China. During this paused period, these countries will face the baseline 10% tariff.
China was not exempted from this recent 90-day pause, and a trade war between China and the US has escalated. US tariffs on exports from China now sits at 145%. China’s retaliatory tariff on exports from the US now sits at 84%.
On 1 February 2025, President Trump also announced a 25% tariff on imports from Canada and Mexico with some exemptions.
Effective on 3 April 2025, all foreign-made cars are subject to a 25% tariff. President Trump had also previously announced a 25% tariff on steel, aluminium, and derivative products, which came into effect on 12 March 2025.
UK exports into the US of cars and car parts, as well as steel, aluminium, and derivative products, are subject to these 25% tariffs.
Some goods are exempt from the reciprocal tariffs, including copper, pharmaceuticals, semiconductors, and lumber articles, as well as energy and certain minerals that are not available in the US.
Given these exemptions, BHTA member exports are unlikely to be exempt from the tariffs.
The situation remains fluid and uncertain and is likely to change over the coming weeks and months.
The tariffs may limit access to the US market for UK firms, as the demand for UK exports may reduce. Restricted market access can hinder growth and expansion opportunities, forcing companies to look for alternative markets or scale down their operations. For SMEs, the additional financial burden will threaten competitiveness, margins, and long-term investments in innovation and R&D.
The supply chain for any components that are sourced from or destined for the US is likely to be disrupted. This disruption can lead to delays and increased operating costs that rely on a seamless flow of goods across the borders.
UK businesses that rely on goods or components from countries and areas that have been affected by higher reciprocal US tariffs could also face increased costs, which will likely affect manufacturing and demand for US goods.
For BHTA members that are manufacturing overseas and importing to the US from a different country, the tariff applied depends on which country it is exported from. For example, if a UK firm manufactures and exports its products from China to the US, China’s reciprocal US tariff would be applied, not the UK’s. It is not yet clear whether the UK Government will intervene or offer support in such circumstances.
As countries around the world may react, or already have reacted, with retaliatory tariffs, this will also have an impact.
Make UK is advising UK businesses to assess the implications of these global tariffs, both directly and indirectly, and think through new commercial, trading, and financial strategies.
Northern Ireland goods that enter the US are subject to the 10% tariff that the US imposed on the UK.
Although Northern Ireland is part of the UK, under post-Brexit arrangements for trade, Northern Ireland remains in the EU single market for goods. This means that for any retaliatory tariffs that the EU imposes on US imports, Northern Ireland will have to follow those EU rules and introduce those tariffs.
The UK Government is offering a reimbursement scheme to Northern Ireland firms if they can demonstrate that goods imported from the US into Northern Ireland are sold there. However, Northern Ireland firms would first be responsible for paying the EU tariffs before a reimbursement application can be made.
The UK Government so far has taken a pragmatic response to the US tariffs, without introducing any retaliatory tariffs.
The UK Secretary of State for Business and Trade’s statement to the House of Commons on 3 April stated the government’s intention is to work with the US on a deal that would reverse the locational and product tariffs that have been imposed.
Prime Minister Keir Starmer echoed these sentiments at 10 Downing Street on 3 April, stating that: “Nobody wins in a trade war. That is not in our national interest.”
The Prime Minister said that the government’s intention is to secure a deal with the US but that “nothing is off the table”.
Now, the government is requesting input from UK businesses on the implications for businesses of possible retaliatory action from the UK Government. This is a “formal” and “necessary” step from the UK Government to keep all options on the table.
In the event that the UK Government reaches an economic deal with the US that lifts the tariffs on the UK, the UK Government says it will pause the input from UK businesses, and any measures flowing from that will be lifted.
Beyond the government’s consultation, so far, no other specific support for UK businesses as a result of the tariffs has been announced or provided by the UK Government.
The UK Government is seeking the views of UK businesses on the implications of possible retaliatory action from the UK Government.
It is a chance for businesses to have their say on the US tariffs and influence the design of any possible UK tariff response if a more favourable deal is not agreed upon.
UK businesses can respond to the UK Government’s request for input here. The request for input from UK stakeholders closes on 11.59pm on 1 May 2025.
The British Healthcare Trades Association (BHTA) has welcomed Merits Health Products UK as a new member. Merits Health Products UK offers manual wheelchairs, powerchairs, rehab powerchairs, mobility scooters, accessibility equipment, stairlifts, patient aids, and seating and positioning products.
The BHTA recently caught up with Frank Robertson, UK Manager of Merits Health Products UK, to learn more about how Frank started at the firm, the company’s extensive product portfolio, and how becoming a BHTA member affirms that the company is ethical, professional, and reputable.
Frank is a professional mechanical engineer with over 35 years’ experience in engineering, manufacturing, and management, including jobs outside of the UK.
In 2018, Frank was looking for a new challenge. He had worked in aerospace, defence, consumer electronics, telecommunications, even environmental services, and banking. He was looking for something different, something that would make a difference to people.
Frank was approved by a recruitment company that was looking for someone with experience of managing diverse engineering teams from different companies and institutions to research, design, and build a leading-edge power wheelchair for young people. A wheelchair that would meet the mobility challenges that young people said they faced every day and also incorporate the latest in technology that could complement a wheelchair.
The project was the Wheels of Change led by the charities Whizz Kidz and Duchene UK and funded by the players of the Peoples Postcode Lottery and Motability Operations.
“It was an extremely challenging project, placing young wheelchair users at the centre of design, and, in spite of the Covid pandemic, we delivered the ambitious Dream Wheelchair prototype in November 2020,” Frank said.
The Dream Wheelchair project was a success, and the charities wanted to investigate if it would be possible to develop it for production and launch it on the market.
Enter Mike Laiman, Global VP Operations of Merits Health Products Co.
Frank explained: “Merits not only designs and builds mobility products under its own Merits, Avid, Pilot, and Precision Comfort brands, but it is also one of the major contract manufacturers of powered wheelchairs and other mobility products.”
Mike saw the potential in the Dream Wheelchair and the similarities it had to the Avid Axcel Front Wheel Drive wheelchair that was already in development. Mike committed Merits to build the Mk2 and Mk3 prototypes of the Dream Wheelchair.
Frank continued: “Sadly, the funding available to Whizz Kidz and Duchenne UK ran out, and Mike asked me to join Merits, which was investigating entering the UK market with its own Avid brand of complex powered rehab wheelchairs, and the rest, as they say, is history.
“I am now the UK manager for Merits, establishing Merits brands in the UK with one eye on Europe, and I still get to work with our engineering and research & development teams in Taiwan and the USA.”
Merits Health Products Co. is a Taiwanese-owned company founded by Larry Cheng in 1986 because his mother required a wheelchair, and he thought he could design and build a wheelchair that could meet his mother’s specific needs better than the wheelchairs available in Taiwan at that time.
Since then, the company has grown to become a global corporation with operations in Taiwan, China, Vietnam, the US, and, from April 2024, the UK.
The current range in the UK includes the Avid brand Axcel and Axcel Narrow, which Frank states is the narrowest front-wheel-drive wheelchair on sale in the UK; the Velocity, the firm’s premium mid-wheel-drive fully featured rehab wheelchair; and the Merits Ultra Mid, the company’s entry-point rehab model that is still highly capable and feature-packed.
The P326e Vision Sport wheelchair launched in the UK at this year’s Naidex.
“It received a lot of attention for its comfortable and easily accessible seating, high manoeuvrability, and good looks,” Frank commented.
Merits Health Products UK recently introduced its Pilot range of stairlifts in the UK. Additionally, the firm has just announced the acquisition of Aergo Health and its patented Air Cell Seating Technology. By focusing on healthy and functional seated posture, Aergo solutions help reduce pain and prevent pressure ulcers.
Frank described the company’s ethos and commitment to high-quality solutions: “At Merits we believe in ‘enhancing life through mobility’. We strive to enable independence and accessibility for all, by providing life-enhancing quality solutions that support people in living their life to the fullest.
“The Merits Health Products logo, consisting of four red hearts, is a symbol of our commitment to provide products second to none. The four red hearts represent faithfulness, caring, love, and untiring determination toward our goal of enhancing human life. We commit to continue our efforts in providing the best possible products and services available at a competitive cost to our customers.”
Merits Health Products is driven to improve lives – every day, all over the world – by making high-quality manual wheelchair, powerchair, rehab powerchair, mobility scooter, accessibility, patient aid, stairlift, and seating & positioning products.
The company provides reliable, expertly engineered solutions for nearly every need. Its innovative designs constitute years of experience and research to fully understand the specific needs of individuals.
“Through years of consultations, personal contacts, and studies, Merits Health Products has adapted every way conceivable to satisfy our customers efficiently with quality and professionalism,” continued Frank.”
Merits Health Products UK has also enhanced laboratory testing capabilities to help customers solve quality challenges and improve product reliability.
The function of the in-house laboratory is not only to meet the test standards and regulations but also to take into account the customer’s reasonable use habits to verify the quality of the firm’s products and to gain the trust of distributors and the trust of end-users in its quality.
Even though it is part of a global corporation, Merits Health Products UK faces the same challenges as any new start-up company.
Frank stated: “The world is a rapidly changing place right now.
“We have ships having to avoid the Suez Canal because of the threat of missile attacks, adding cost and time to supply chains. The growing threat of a trade war through the implementation of tariffs.
“It is beyond us as a company to avoid these global issues, but our global footprint allows us to manufacture our products in the right locations to minimise the impact such issues have on everyone.”
Merits Health Products UK believes it has the right products for the UK market and is now working to build a network of dealers to represent it across the UK. This is so that users everywhere can have access to its products in the knowledge that they have a local dealer supported by a multinational mobility company that believed in making a difference to people’s lives.
Merits Health Products UK is looking to expand its current product range. It already has in development new powerchairs that have been designed specifically for the UK market to cope with the infrastructure challenges that exist in the UK and Europe.
The plan is to launch these products at Rehacare in September, where the company will have a large stand with Merits Health Products employees from around the world. At Rehacare, the company will further exhibit a wide variety of products from its different brands.
The BHTA is a trade association in the healthcare and assistive technologies arena, working on behalf of its members to improve industry standards and consumer protection. With more than 400 members of retailers, installers, service providers, distributors, and manufacturers, this represents many of the current and future companies Merits Health Products UK wants to work with and as its customers.
“What better way to demonstrate to them the standards and values we believe in than to join a trade association that they are also members of?” Frank explained.
Merits Health Products UK believes that being a member of the BHTA demonstrates to the mobility sector that it is a moral company with high ethical standards that can be a trusted supplier to their business.
Being a part of the BHTA means that the company has to conform to the BHTA Code of Practice. This code ensures that the mobility and healthcare community who need Merits Health Products UK’s products can trust that the company is professional, ethical, and has their best interests at heart.
Frank highlighted another important benefit of being a BHTA member: “We also recognised strong BHTA membership provides an opportunity for its members to interact and engage with regulatory and standards-setting bodies, both domestic and international, and to be a part of the BHTA’s activities, improving standards for the provision of quality healthcare and assistive technology products and services.”
Merits Health Products UK plans to attend the Future of Medtech conference on the 13th of May in Northampton, as the company sees immense value in the potential to introduce new technological innovations, such as the IoT.
The firm also plans to attend the South West Regional Networking event in Bristol on the 8th May, where it hopes to find out other members’ interests and what they require from a supplier like Merits Health Products UK.
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
On 13 March 2025, Prime Minister, Keir Starmer, announced that NHS England (NHSE) will be formally abolished.
Health and Social Care Secretary, Wes Streeting, confirmed that NHSE will be brought into the Department of Health and Social Care (DHSC) entirely over the next two years.
It is a decision that is supposed to avoid excessive duplication and inefficiencies between NHSE and DHSC. This major reform is also designed to cut bureaucracy, free up capacity, and deliver savings of hundreds of millions of pounds a year, according to the government.
The abolition of NHSE will be phased over the next two years, during which time it will take on a new and more focused role. Under the leadership of the recently announced NHSE executive team, during this transition period, it will:
The government has made clear that local NHS providers and integrated care systems (ICSs) will have more autonomy, with NHSE stepping back from detailed operational oversight. Waiting time targets and financial frameworks will remain but with greater flexibility for local leaders to decide how to meet them.
Of the combined 17,900 workforce across both NHSE and DHSC, it is expected around 9,000 will go, which means the new and clearly more powerful DHSC team will have around 9,000 staff.
While the political message is clear, the legal process is more complicated. The 2012 Health and Social Care Act legally enshrined NHS England’s independence, meaning that some legislative change will be needed to fully dissolve its infrastructure. However, Wes Streeting has confirmed that much of the change can be delivered without the need for primary legislation, stressing that “time is of a premium” and that the government will “immediately work forward” to begin the transition.
While some aspects of NHSE’s absorption into the DHSC can be enacted through secondary legislation and administrative restructuring, there will still be a need for primary legislative change at some stage. The government is working with the Leader of the House to secure an appropriate timetable, ensuring that the necessary legal adjustments are made without derailing other parliamentary priorities.
It is not yet clear what the procurement landscape will look like with NHSE’s abolishment.
“[DHSC] is tasked with realising the untapped potential of our National Health Service as a single-payer public service, getting a better deal for taxpayers through central procurement, being a better customer to medical technology innovators to get the latest cutting-edge tech into the hands of staff and patients much faster, and being a better partner to the life sciences sector to develop the medicines of the future.”
Wes Streeting
However, NHS Supply Chain, which currently reports to NHSE, is responsible for centralised procurement of products and services into the NHS, which leads to uncertainly around which body will be responsible for procurement going forwards and how centralised procurement may change.
Likewise, it is not yet clear what will happen to the NHS Central Commercial Function (CCF), which owns Sustainability and Social Value, Med Tech Stakeholder Management, and Value-Based Procurement (partially).
For BHTA members, navigating any changes to procurement could be complicated, time-consuming, and challenging. We urge the government to ensure any changes are communicated clearly and with as much time as possible, straightforward, consistent, and as seamless as possible to minimise disruption to vital healthcare services.
The MedTech Directorate is set to become more powerful over these next two years, with around 7,000 new staff transitioning in from NHSE. Tasked with building a thriving UK MedTech sector, the body’s remit covers reviewing how medical devices are regulated, commissioned, and used on an ongoing basis.
The current MedTech Directorate Director, David Lawson, who came into post in 2022 will, the BHTA believes, have a much wider portfolio of responsibilities and will need a larger management structure to manage the various pillars of activities. There will now be a direct line from the centre to the ICSs so the pace change will be enhanced and as stated by the Secretary of State, ICSs will have more autonomy.
Any changes to the governance and restructuring of the MedTech Directorate will likely impact BHTA members, who may be subject to new processes. Again, we urge the government to ensure any changes are communicated clearly and with as much time as possible, straightforward, and as seamless as possible to minimise disruption to vital services.
Off the back of NHS England being abolished, here are the key questions that the BHTA, BHTA members, and the industry more broadly need answers for:
On 26 March, Chancellor of the Exchequer, Rachel Reeves, delivered the Spring Statement 2025, which delivers the UK Government’s spending plans and the economic outlook for the financial year ahead.
However, no new funding was announced for healthcare and assistive technology equipment providers, the NHS, or social care. This comes off the back of the recent major news that NHS England will be officially abolished.
David Stockdale, Chief Executive of the British Healthcare Trades Association (BHTA), responded to the statement: “No new funding for the health and care sector, NHS England being abolished, and businesses having to pay increased employer National Insurance Contributions (NICs) from next month lead to a worryingly economically uncertain position for our members.
“We have already expressed major concerns over the employer NIC hike and the impact this will have on our members. Many of our members are SMEs that are tied to fixed-price contracts with NHS suppliers and local authorities, and rising business costs could make them completely unsustainable.
“Pair this with no new funding for the NHS and social care as well as the procurement landscape set to change with the abolishment of NHS England and it means BHTA members are operating in an unstable landscape.
“We’re calling on the government to provide clarity on what will happen to NHS Supply Chain and procurement more broadly as well as provide funding for healthcare equipment providers to ensure that essential services are not decimated and people can continue getting the vital products they need.”
This article has been co-authored with legal input from Addleshaw Goddard and reviewed by two BHTA members.
Under UK laws businesses, including British Healthcare Trades Association (BHTA) members, must ensure their Google Ads and other marketing materials are transparent and not misleading – particularly if they are consumer-facing.
Many consumers purchasing from BHTA members—such as older adults, disabled individuals, and those with long-term health conditions—may be considered vulnerable consumers. These individuals may face barriers to understanding pricing structures, including VAT relief eligibility, so making clear and accessible information is crucial. Misleading or unclear pricing could lead to confusion, financial strain, and a lack of trust in suppliers of essential healthcare products.
Currently, businesses comply with the Consumer Protection from Unfair Trading Regulations 2008.
Failure to comply with the Digital Markets Competition and Consumers Act 2024 could lead to significant penalties, including fines of up to 10% of annual global turnover as well as individual penalties, compensation, and direction to change behaviour.
For BHTA members, ensuring VAT pricing is clearly displayed in Google Ads is likely a legal requirement but also a matter of ethical responsibility to protect vulnerable consumers. Given the complexities of VAT relief, businesses must take extra care in their advertising to ensure pricing transparency, accessibility, and compliance with consumer protection laws. Clear and upfront pricing helps prevent confusion, build trust, and avoid enforcement action (which is now led by the Competition and Markets Authority (CMA)).
Prime Minister Keir Starmer has announced that NHS England (NHSE) will be formally abolished.
“I’m bringing management of the NHS back into democratic control, by abolishing the arms-length body NHS England,” Keir Starmer said during his speech yesterday about reforms to the civil service and the way the UK Government works.
The Prime Minister said the decision to abolish NHSE will avoid excessive duplication and inefficiencies between NHSE and the Department for Health and Social Care (DHSC).
It is a move designed to “cut bureaucracy across the state”, “focus government on the priorities of working people”, and “shift money to the frontline”, according to Keir Starmer.
“That will put the NHS back at the heart of government where it belongs”, the Prime Minister remarked.
This major reform also claims to free up capacity and deliver savings of hundreds of millions of pounds a year.
NHSE leads the National Health Service (NHS) in England. NHSE is an executive non-departmental public body, sponsored by the DHSC. The organisation was created in 2012 by the then Conservative Government to handle day-to-day running as part of a reorganisation of the NHS.
The government says that work will begin immediately to return many of NHSE’s current functions to DHSC. Health and Social Care Secretary, Wes Streeting, said that NHSE will be brought into the DHSC entirely over the next two years.
Importantly, DHSC says that it will also realise the untapped potential of the NHS as a single payer system, using its centralised model to procure cutting-edge technology more rapidly, get a better deal for taxpayers on procurement, and work more closely with the life sciences sector to develop the treatments of the future.
The abolishment of NHSE also promises to give more power and autonomy to local leaders and systems so they are given the tools and are trusted to deliver health services for the local communities they serve with more freedom to tailor provision to meet local needs.
For BHTA members, many of whom provide essential healthcare equipment and assistive technologies to the NHS and local authorities, this promise of less bureaucracy and more rapid deployment of cutting-edge technology through a more centralised procurement model should come as welcome news. Although, it is not yet clear how the abolishment of NHSE will affect NHS Supply Chain and its procurement activities. It leads to questions about the broader NHS infrastructure as well.
David Stockdale, Chief Executive of the British Healthcare Trades Association (BHTA), commented on the news: “In theory, the idea of abolishing NHS England to reduce duplication across NHSE and DHSC and speed up procurement of cutting-edge technology is great news.
“We’ve heard from members many times that the procurement process across the NHS is fragmented, inconsistent, and unnecessarily complicated.
“In practice, we hope that this major change leads to our members not having to re-submit the same details every time they apply for an NHS contract, local NHS systems selecting innovative and value-adding healthcare products over simply the lowest price, and a consistent, straightforward procurement process across England.
“Our upcoming conference is a great chance for BHTA members and non-members alike to hear directly from senior leaders at NHS Supply Chain who will be able to shed some light on this major reform. Conference tickets can be purchased here.”
The British Healthcare Trades Association (BHTA) is detailing the results of its autumn 2024 membership survey, which received 38 responses.
The quarterly surveys are designed to get a snapshot of the current BHTA membership, including the members’ nature of business, annual turnover, company size, outlook for future business activity, and the challenges that members are facing.
Most of the respondents came from the mobility (12), stoma and continence (10), and independent living (9) sections, but there was representation across all 12 BHTA Sections. Manufacturers, distributors, retailers, installers, community services providers, NHS services providers, importers, and exporters all responded.
There was a good mix of sole traders, SMEs, and large businesses that participated in the survey. This ranged from two employees, to 50 employees, all the way up to over 500 employees and everything in between.
The image below shows respondents’ annual turnover for the last financial year.
When asked about how optimistic they were about the wider UK economy over the next 12 months, one respondent replied ‘very optimistic’, 10 said ‘optimistic’, 14 said ‘neutral’, 12 said ‘pessimistic’, and one said ‘very pessimistic’. This response has remained very similar compared to the BHTA’s autumn 2023 and spring 2024 membership surveys.
When asked about how optimistic they were about their organisation over the next 12 months, 18 percent said ‘very optimistic’, 61 percent said ‘optimistic’, and 21 percent said ‘neutral’. No members felt pessimistic. This is a downwards trend compared to the BHTA spring 2024 membership survey.
When asked about how optimistic they were that the UK Government understands and will address key issues facing the sector over the next 12 months, the feeling was more pessimistic overall. 11 percent felt optimistic, 16 percent felt neutral, 58 percent felt pessimistic, and 16 percent felt very pessimistic. This is a downwards trend compared to the BHTA spring 2024 membership survey.
The image below shows members’ outlook for their organisation will be in terms of investment, headcount, revenue, and export, comparing the next 12 months with the previous 12 months.
Members cited higher manufacturing costs as the main challenge facing their business. Higher distribution costs, staff recruitment, supply chain challenges, and procurement processes were also mentioned as challenges.
When asked about their business’ ability to interact with, and directly export to, foreign markets over the next 12 months, two felt very optimistic, nine felt optimistic, four felt neutral, four felt pessimistic, and two felt pessimistic. The question was not applicable to the other respondents.
In terms of receiving BHTA updates, members prefer receiving emails from their membership engagement managers, in Section meetings, or via the monthly BHTA newsletter.
The image below shows members’ feelings towards the BHTA’s work in terms of most and least important to their business.
Finally, when members were asked about what activity they would like to see the BHTA undertake in 2025, there was a range of responses. These included market sizing reports and annual trends, continuing the work to scrap VAT on defibrillators, more political engagement by building on the BHTA’s successes, seminars discussing across-industry challenges such as green procurement requirements, and continuing the work with Drug Tariff review.
The Department of Health and Social Care (DHSC) recently announced reforms and an independent commission to help improve adult social care.
As part of the plans to “transform” adult social care, the UK Government unveiled a new £86 million funding boost to the Disabled Facilities Grant (DFG) this financial year. This is in addition to the £86 million announced for the next financial year at the Autumn Budget 2024, taking the annual total for DFGs to £711 million.
As part of long-term reform of the adult social care system, the government wants to create a national care service underpinned by national standards.
As a first step, the government will launch an independent commission into adult social care, to be chaired by The Baroness Casey of Blackstock DBE CB, to inform the work needed to deliver this.
The commission, reporting to the Prime Minister, will make clear recommendations for how to rebuild the adult social care system to meet the current and future needs of the population.
Split over two phases, the commission will set out a vision for adult social care, with recommended measures and a roadmap for delivery.
The first phase, reporting in 2026, will identify the critical issues facing adult social care and set out recommendations for reform and improvement in the medium term.
It will recommend tangible, pragmatic solutions that can be implemented in a phased way to lay the foundations for a national care service. The recommendations of this phase will be aligned with the government’s spending plans, which will be set out at the Spending Review in spring.
The second phase, reporting by 2028, will make longer-term recommendations for the transformation of adult social care. It will build on the commission’s first phase to look at the model of care needed to address the UK’s ageing population, how services should be organised to deliver this, and how to best create a fair and affordable adult social care system for all.
Reacting to the plans for social care reform, David Stockdale, Chief Executive of the British Healthcare Trades Association (BHTA), commented: “The BHTA overall welcomes the government’s recent proposals for social care reform.
“The £86 million funding for DFGs is encouraging. Many of our members provide assistive products that facilitate life-changing home adaptations, so this additional funding means that more people can have access to these crucial pieces of equipment.
“However, the BHTA has previously expressed concern about the consequences of the increases in employer National Insurance Contributions and the National Living Wage on businesses.
“We again encourage the government to rethink the impact of these additional costs for businesses – which the government will rely on to deliver this additional activity within the DFG – so that wider health and social care services aren’t negatively impacted as a result.
“As for the independent commission, the government shouldn’t overlook the importance of healthcare and assistive technology products in helping people to remain independent and healthy. The right products provided in a timely manner can help avoid unnecessary hospital admissions, enable people to stay in their own homes for longer, and ease pressure off an overworked and under-resourced care sector.
“Our members provide the local expertise, products, and services required to help the government achieve its vision of a national care service that meets the needs of older and disabled people.
“However, the timeline for the commission is a major concern. There is worry about what the impact of ‘kicking the can down the road’ will be for businesses supporting social care and what the landscape will look like if no action is taken until the commission’s final publication date of 2028.
“We invite the government to engage with the BHTA and assistive technology community to see what transformational actions can be implemented now.”
Welcome to the 2023-2024 Annual Review of the British Healthcare Trades Association (BHTA).
We appreciate you taking the time to reflect on our activities and achievements over the past year.
The winners of the British Healthcare Trades Industry Awards 2024 have been announced across eight categories.
Hosted by the British Healthcare Trades Association (BHTA), the glittering awards ceremony celebrated excellence in the healthcare and assistive technology industry. It took place at the Grand Hotel Birmingham on 29 November to commemorate the exceptional accomplishments of BHTA members, non-BHTA members, healthcare professionals, and industry partners.
Throughout the evening, attendees had the chance to network with industry peers, enjoy a tantalising three-course dinner in the hotel’s grand ballroom, and hear about the inspirational achievements of the award winners.
Melissa Johns presented this year’s awards ceremony. She is a fierce advocate for diversity and inclusion in all industries. Born without a right forearm and hand, Melissa was named one of the UK’s 100 Most Influential Disabled People and one of JCI’s Ten Outstanding Young Persons of the World.
There were eight award categories at the British Healthcare Trades Industry Awards 2024:
Richard Holland-Oakes won the Lifetime Service Award. Over his 45 years in the industry, Richard has worked with a number of recognisable names, like Ottobock, Sunrise Medical, Permobil, and Recare. Throughout this time, he has led the industry in service standards.
The judges were particularly impressed with his passion for inclusion. His nomination made it clear that Richard doesn’t just own or help run his company; he is hands-on and actively builds a legacy of compassion, understanding, and engineering excellence. In addition, he is an active supporter of the industry as a whole and remains a staunch supporter of the BHTA, its values, and mission.
Rollz’s Motion Electric won the Product of the Year Award. The Motion Electric revolutionises mobility aids by merging the functionality of a rollator, transport chair, and electric wheelchair. This fulfils a crucial gap in the market for individuals with varying mobility needs.
A special additional Highly Commended Award was also given to Ottobock’s Genium X4, as the judges recognised this as another exceptional product. The Genium X4 microprocessor knee supports smooth, real-time transitions from sitting to activity. Each step is constantly monitored to monitor change of speed. With improved water durability and battery life, the knee is described as the ‘Swiss Army Knife’ of MPKs.
The OT Show won the Best UK Trade Show Award. This award was voted on by BHTA members, who were impressed with the variety of sessions, speakers, and workshops all supporting a common and united purpose. With a clear audience, the OT Show provided many trade opportunities for conversation and collaboration.
Mobility Scotland won the Retailer of the Year Award. Mobility Scotland’s nomination emphasised its company objectives of “Right, first time, every time”along with a commitment to value. Its unique approach of long-lasting customer relationships is supported by the fact that Mobility Scotland does not advertise through mainstream sources, relying instead on word of mouth, with over 70 percent of business coming from returning customer and referrals.
Laura Wilson won the Rising Star Award. Laura leads the Steeper Product Evaluation Group in Orthotics, and during her tenure she has streamlined the process. She has constantly sought training and new opportunities, including travelling to France and Germany to build relationships and source products. Her work has had clear success both in financial terms and in improving patient outcomes.
Care & Independence won the Manufacturer of the Year Award. The judges were impressed not only by Care & Independence’s established market presence and commitment to customer engagement, but also by its investment in and encouragement of new and innovative ways of thinking and best practices. Care & Independence has a near 40-year heritage.
Reliance Medical won the Innovation in Sustainability Award. Reliance Medical showcased a robust and thoughtful approach to sustainability, with a company fleet of electric or hybrid vehicles, an energy-efficient building complete with rooftop solar farm, and a designated employee Green Team action group. Additionally, it has launched several fully recycled and recyclable products, with a goal that all its first aid consumables will be free of plastics by 2025.
Opcare won the Outstanding Community Outreach Award. The Opcare team goes above and beyond in making a significant contribution to its community. Many new equipment users have difficulty in accessing guidance and learning about their instruments. These difficulties can include transportation, capabilities, or availability. Opcare developed a series of satellite clinics around Leicestershire, which, in addition to providing equipment and expertise, also delivered equipment to patients’ homes.
Commenting on the British Healthcare Trades Industry Awards 2024, David Stockdale, CEO of the BHTA, said: “Thank you to everyone that attended this year’s British Healthcare Trades Industry Awards and a big congratulations to all of the award winners. It was a brilliant event to celebrate the sector’s exceptional achievements.”
On 29th December 2024, BHTA held its Industry Awards Ceremony in the Grand Hotel, Birmingham. Aimed at celebrating excellence within the industry, the night brought together members from across the association for a night of good food, 8 awards categories, and dancing.
The event was hosted by Melissa Johns, an actor and writer who champions diversity and inclusivity in the arts, and who was born without her right forearm and hand.
See the day in pictures below:
The British Healthcare Trades Association (BHTA) has welcomed Meyra UK as a new member. Meyra UK offers a comprehensive range of mobility solutions, which include sports wheelchairs, powerchairs for complex rehabilitation needs, and an extensive paediatric range.
The BHTA recently caught up with James Malcolm, General Sales Director UK & Ireland at Meyra UK, to find out more about James’ background in the mobility industry, the firm’s focus on strengthening partnerships with dealers and distributors, and the value of becoming a BHTA member.
James has over 15 years of experience in the mobility sector, as he explains: “It feels like a lifetime ago, but my journey in the mobility sector began in 2007 as an area sales manager.
“Since then, my career has evolved significantly. I’ve had the privilege of working with some of the leading manufacturers, service providers, and retailers in the industry, alongside many dedicated professionals committed to delivering high-quality products and services to a diverse range of end-users.
“These experiences have provided me with valuable insights and a deeper understanding of the mobility sector, fostering both my professional and personal growth. This journey has ultimately led me to my current role at Meyra UK.”
Meyra UK is part of the globally respected Meyra Group, which was founded in Germany in 1936. Renowned for its user-centred design and innovation, Meyra offers a comprehensive range of mobility solutions. These include configurable, active, and sports wheelchairs; e-powered chairs for daily use and complex rehabilitation needs from Meyra and the TA service; and the Netti range for users requiring advanced seating and positioning.
“Additionally, we offer an extensive paediatric and bariatric range,” adds James. “Our product portfolio is extensive.”
Meyra products have been in the UK for many years, but Meyra UK is now focusing on strengthening its partnerships with dealers and distributors. By collaborating closely, Meyra UK strives to provide them with the tools and support needed to deliver its innovative mobility solutions effectively across the UK and Ireland.
Meyra UK’s ethos is all about inspiring the joy of life for end-users, their families, caregivers, and all other parties involved in the process of offerings its products to the end-user.
The firm decided to become a BHTA member for multiple reasons, among them being the association’s ability to effectively lobby on behalf of its members, valuable networking opportunities, and adding credibility to the business.
“I have been a supporter of the BHTA since I entered the industry,” said James.
“Upholding ethical standards and best practices is crucial for the mobility sector, and collaboration between OEMs, service providers, and distributors is essential to ensure that users—whether accessing products through contracts or private purchase—receive high-quality solutions that adhere to best practices and the BHTA Code of Practice.
“The BHTA also plays a vital role in advocating for our industry with governments and regulatory bodies, both old and new.
“Being a member of the BHTA adds credibility to our business, provides access to valuable industry insights, and connects us with a supportive community that is dedicated to advancing healthcare and independent living solutions.”
Like all OEMs, Meyra UK faces various challenges. It focuses on leveraging advanced technologies and developing new products to meet the evolving needs of its customers. Additionally, the company is committed to environmental responsibility and sustainability in our operations and product designs.
James discusses how the BHTA can assist in this area: “The BHTA can support us by advocating for policies that promote environmental sustainability and reduce regulatory burdens. Furthermore, the BHTA can facilitate networking opportunities and partnerships within the industry to share best practices and innovations.”
One of the biggest draws for becoming a BHTA member is the chance to network with like-minded industry peers. James is already taking advantage of this.
“I recently joined an online meeting with leading retailers in the industry, which was highly informative,” he comments. “I look forward to attending additional BHTA events, as these are invaluable for staying informed on industry trends, networking with other professionals, and discussing key issues in the sector.”
There are some exciting developments ahead for Meyra UK, with new products and events on the horizon. The company will be attending Naidex 2025 and is also planning several product roadshows and workshops across the country.
“We recently showcased our innovative Gaze Driver, an eye-control system for powered wheelchairs, at Rehacare in Dusseldorf, and the response was very positive,” says James. “We are planning to launch it in the UK next year.
“Additionally, we will be unveiling new products in our Active range, thanks to our continued collaboration with designer Rainer Küschall, as well as new innovations in our E-Power range.”
Meyra UK also plans to grow the UK team and will actively be recruiting throughout 2025 as part of its expansion plans.
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
Safespaces, a member of the British Healthcare Trades Association (BHTA), has been honoured with a King’s Award for Enterprise in Innovation.
Now in its 58th year, the King’s Award for Enterprise is the most prestigious business award in the UK and recognises companies that have demonstrated outstanding innovation in their field.
One of only 59 organisations to be recognised with this coveted award, Safespaces secured the award as a result of its pioneering work in creating adaptable spaces and beds for individuals with complex needs.
Each product is designed to meet the unique needs of the user to improve safety and provide a sensory-friendly environment. Safespaces customers consistently report significant improvements to the individual’s well-being, sleep patterns, and anxiety levels, as well as providing peace of mind to their caregivers.
Alastair Demick, Managing Director of Safespaces, said: “Every member of the Safespaces family cares passionately about the work we do to help and support families and individuals with complex needs, and I am delighted that their hard work and dedication has been recognised with the King’s Award for Enterprise in Innovation.
“Innovation was the driving force behind Safespaces when the founders began this journey in 2001, and we are just as committed today to drive innovation in creating spaces and beds that truly make a difference in people’s lives.
“It is an honour to receive such a prestigious award, and we look forward to an exciting future supporting OTs and families through the provision of innovative, safe, sensory-friendly environments that enhance the well-being of our users.”
On 30 October 2024, Chancellor of the Exchequer Rachel Reeves delivered the Labour Party’s Autumn Budget to Parliament, detailing the UK Government’s tax and spending plans for the year ahead.
The topline announcements that will impact British Healthcare Trades Association (BHTA) members have been highlighted below.
Rachel Reeves announced that there will be no increase to National Insurance, VAT, or Income Tax for employees. Income Tax and National Insurance Contributions (NICs) thresholds will be unfrozen from 2028-29 onwards, which means that people will not be moved into higher tax brackets until then.
However, from 6 April 2025, the government is increasing the rate of employer NICs from 13.8 percent to 15 percent. In addition, the threshold at which businesses start paying National Insurance on a worker’s earnings will be lowered from £9,100 to £5,000.
The smallest businesses will be protected from this change, as the Employment Allowance will increase to £10,500 from £5,000 and be extended to all eligible employers by removing the £100,000 cap. The UK Government says that this means that 865,000 employers will pay no NICs next year.
The Autumn Budget 2024 also revealed that the National Minimum Wage will be increased by 6.7 percent, from £11.44 an hour to £12.21 hour, for people aged 21 and over. The National Minimum Wage will rise for people aged between 18 and 20-years old from £8.60 to £10.
Additionally, the weekly earnings limit for Carer’s Allowance will be increased to 16 hours at the National Living Wage, worth an additional £45 a week from April next year.
One of Labour’s seven key pillars for growth is to drive innovation with increased funding of STEM industries.
The chancellor also announced that Labour is setting a two percent productivity, efficiency, and savings target for 2025/26 for every government department.
Off the back of Lord Darzi’s independent review of the NHS, a 10-year plan for the NHS is due to be published by the government in spring 2025. This plan will set out reforms to transform the NHS from analogue to digital and more from model of sickness to prevention shift care from hospital to community.
In the budget statement, the chancellor confirmed an additional £22.6 billion for day-to-day spending over two years for the Department of Health and Social Care (DHSC), supporting Labour’s goal for the NHS to deliver an extra 40,000 elective appointments per week.
The settlement also confirms capital spending for DHSC will increase by £3.1 billion in 2025‑26 compared to 2023-24 outturn, rising to £13.6 billion, representing record levels of capital investment into health and a two-year average real terms growth rate of 10.9 percent.
Further investments into the NHS included £1 billion for a special fund to address physical infrastructure plus £1.5 billion for new diagnostic centres.
Additionally, Rachel Reeves announced £600 million of new grant funding to support social care. This is alongside an £86 million increase to the Disabled Facilities Grant (DFG).
Responding to the Autumn Budget 2024, David Stockdale, Chief Executive of the BHTA, said: “While we fully welcome additional funding for the NHS and local authorities, we are deeply concerned about the impact of rising costs on the private sector.
“Many of our members are small and medium enterprises, tied to fixed-price contracts with NHS suppliers and local authorities, and rising business costs could make them completely unsustainable.
“Taking on increased National Insurance and the Minimum Wage will be particularly costly without support. In fact, we are already hearing that without support this could ‘decimate’ vital sectors, like community equipment.
“Tax increases and other escalating business expenses threaten to offset any additional investment being made by the government. The hundreds of SMEs that we represent will bear the brunt if this budget despite the fact that we supply the NHS with the essential tech and products necessary to deliver timely, effective care. We stand ready and willing to work with the Government to ensure that this investment is not eroded by increased tax burdens on businesses.”
British Healthcare Trades Association (BHTA) member Prism Healthcare has announced the acquisition of Joerns Healthcare UK on 30 October 2024.
It means that Joerns Healthcare UK’s business, which is also a BHTA member company, and its well-known Oxford range of products, is now part of the Prism Healthcare Group.
With a heritage dating back to the 1950s, Oxford is one of the leading brands in the patient handling and rehabilitation product markets. The Oxford brand specialises in clinical hoisting equipment, slings, and bathing equipment.
The Oxford product ranges represent a strategic addition to the Prism Healthcare Group, which is dedicated to transforming lives in the home, long-term care, acute care, and paediatric settings.
Prism will take on board the full Oxford product set, including the ‘Professional’ and ‘Classic’ ranges, as well as complementary bathing products, slings, and other products supplied by Joerns UK.
Within its core UK market, Joerns UK is a supplier to the community equipment market via loan store operators and independent local authorities, as well as to NHS trusts, care homes, and dealers.
The acquisition of Joerns UK is expected to strengthen Prism’s position as one of the UK’s leading providers of safe patient handling, pressure area care, and specialist seating equipment for individuals with limited mobility.
Chris Morgan, Managing Director of Joerns UK, will take on an expanded role within the enlarged Prism group. He will lead Prism’s UK Homecare and Acute Care businesses, including leading the Joerns UK team within the enlarged UK group.
Chris commented: “I am delighted to have the opportunity to join the Prism Healthcare Group in this exciting new era and to continue the positive development of our company.
“I love working with the fantastic people in this industry and am delighted that the Prism group will support us to continue our successful growth. This will be for the shared benefit of our customers, our team and our supply chain partners.”
Jason Leek, CEO Prism Healthcare Group, added: “The Oxford range of products is an exciting addition to the Prism Healthcare Group. This acquisition strengthens our product offering, supports our expansion into the acute market, and, most importantly, allows us to provide our customers a broader offer.
“I am very excited that we can expand the value-add offering for our customers as well as enhancing our relationships with our suppliers. I am delighted to welcome Chris Morgan and the Joerns team to the group and look forward to working together.”
On 23rd October 2024, BHTA held a Parliamentary drop-in event to ask MPs to pledge their support for the Scrap The Heart Restart Tax campaign. The campaign, fronted by 20-year-old Jack Hurley, who collapsed whilst playing football last June and was saved by the local club defibrillator, is calling for the VAT tax applied to these life-saving devices to be scrapped.
Removing this extra cost (which can be up to £500), would make defibrillators more affordable, meaning more can be bought and made available in local communities.
The drop-in event, held at Westminster, was attended by over 65 parliamentarians, including opposition frontbenchers and members of the Health and Social Care Select Committee.
Jack and BHTA CEO, David Stockdale, also handed a petition to No.10 Downing St., signed by over 85,000 people in support of the campaign.
See the day in pictures below:
The UK Government has published an open consultation, which invites businesses to share their feedback on its new ‘Invest 2035: The UK’s Modern Industrial Strategy’ green paper.
The green paper will inform the development of the government’s new Industrial Strategy, which is the proposed plan to ease the investor journey and create long-term, inclusive, secure, and sustainable growth in the UK business sector. The final Industrial Strategy will be published in spring 2025, alongside the multi-year Spending Review.
Now the government is asking businesses to share their feedback on this green paper. It is seeking companies’ views on the government’s approach, including evidence, analysis, and policy ideas.
This deadline to respond to the consultation is 11.59pm on 24 November 2024. Respond to consultation via this link.
For BHTA members, the government’s new ‘Invest 2035: The UK’s Modern Industrial Strategy’ green paper is a chance for them to help shape the future of UK business and highlight the importance of the healthtech sector.
Published by Business and Trade Secretary, Jonathan Reynolds, and the Chancellor of the Exchequer, Rachel Reeves, the green paper sets out the government’s vision for a modern Industrial Strategy.
The Industrial Strategy is a 10-year plan that is designed to drive long-term growth in key sectors that is sustainable, resilient, and distributed across the country. It promises to deliver the certainty and stability businesses need to invest in the high-growth sectors that will drive the government’s growth mission.
The strategy’s goal is to capture a greater share of internationally mobile investment in strategic sectors and spur domestic businesses to boost their investment and scale up their growth, which the government states is an essential step in achieving sustainable, inclusive and resilient growth.
The key sectors the government will focus its modern Industrial Strategy on are advanced manufacturing; clean energy industries, creative industries; defence; digital and technologies; financial services; life sciences; and professional and business services.
In the next stage of development of the Industrial strategy, the government will prioritise subsectors within these broad sectors that meet its objectives and where there is evidence that policy can address barriers to growth. Ambitious and targeted sector plans will be designed in partnership with business, devolved governments, regions, experts, and other stakeholders, through bespoke arrangements tailored to each sector.
As BHTA members are at the forefront of the healthtech industry, it is important to respond and shape the next 10 years of industry.
The Department of Health and Social Care (DHSC) has published a new strategy that is designed to radically cut the number of single-use medical devices in the NHS.
Disposable medical devices substantially contribute to the 156,000 tonnes of clinical waste that the NHS produces every year in England alone. DHSC says this major crackdown on waste in the NHS will save millions of pounds a year.
The new strategy, ‘Design for Life Roadmap’, means that BHTA members that manufacture medical devices should focus on producing sustainable products, as the NHS is slashing waste and prioritising reuse, remanufacturing, and recycling.
Doing so will create thousands more UK jobs and help transform the country into a life sciences superpower, according to the UK Government. As it stands, millions of devices, like walking aids and surgical instruments, are thrown away after just one use.
The government will encourage more innovation to safely remanufacture a wider range of products and drive costs down, including by changing procurement rules to incentivise reusable products and rolling out examples where hospitals are already leading the way on cutting wasteful spending and practices.
Approximately £10 billion each year is spent on medical technology like this in the NHS, but too much of it is imported via vulnerable routes that risk disrupting patient care, the government states.
Health and Social Care Secretary Wes Streeting said: “The NHS is broken. It is the mission of this government to get it back on its feet, and we can’t afford a single penny going to waste.
“Because the NHS deals in the billions, too often it doesn’t think about the millions. That has to change. This government inherited a £22 billion blackhole in the public finances, so we will have a laser-like focus on getting better value for taxpayers’ money.
“Every year, millions of expensive medical devices are chucked in the bin after being used just once. We are going to work closely with our medical technology industry, to eliminate waste and support homegrown medtech and equipment.”
In one case study, Mid Yorkshire Trust uses 330,000 single-use tourniquets in a year, but a single reusable tourniquet can be used 10,000 times. In a one-year trial, reusable alternatives saved £20,000 in procurement costs and 0.75 metric tonnes of plastic waste.
The Design for Life programme will reduce this kind of waste and achieve an NHS-wide move to sustainable alternatives, also supporting the government’s net zero goals. The new roadmap sets out 30 actions to achieve this shift, including how the government will work with companies to encourage the production of more sustainable products, along with training for NHS staff on how to use them.
Taking this approach will mean more money can be spent in the UK, DHSC underlines, driving growth and creating more engineering, life sciences, and research jobs, while securing savings for the NHS budget.
Many of these products include precious metals such as platinum and titanium, which are in high demand but go to landfill when they could be recovered and sold. A reduction in the amount of disposed single-use devices will also reduce the country’s carbon footprint and plastic pollution.
The government will encourage industry figures to innovate by making sure benefits of reusable medtech are part of how the NHS chooses the products it buys.
The Design for Life programme was developed with more than 80 stakeholders from the UK medtech industry, the health and care system, and research organisations.
The British Healthcare Trades Association (BHTA) has welcomed ISKOmed UK as a new member. ISKOmed UK is the UK subsidiary of ISKO Koch GmbH, which designs and manufactures specialist medical device equipment.
The BHTA recently caught up with Greg Whelan, Managing Director of ISKOmed UK, to learn more about Greg’s background, the firm’s range of specialist products, and how being part of the BHTA can help lobby for important change.
“The journey to ISKOmed UK has been quite an interesting one,” Greg exclaimed.
In 2017, Greg joined Nexus DMS (the exclusive ISKO Koch UK distributor), which was soon taken over by Apex Medical. In 2022, Greg was promoted to Director. At the same time, the ISKO Koch agreement amicably ended with the now rebranded Wellell.
Greg said: “Roll onto 2024 and I realised I loved the ISKO products and sector. The opportunity arose for me to join ISKOmed UK, and the rest is history.
“It’s been an inspirational journey in the healthcare sector so far. I’ve learnt so much from all those I’ve worked alongside, met incredible people, made local and international friends, but, most of all, being part of something that absolutely makes a difference to people’s lives, for me, is truly why I do this.”
ISKOmed UK is the UK subsidiary of ISKO Koch GmbH, which is a designer and manufacturer of specialist medical device equipment. In the UK, ISKOmed UK markets and demonstrates its range of specialist beds for individuals with more complex needs.
Greg said: “With the newly rebranded Rotadorm (previously Rotapro) representing our rotational chair bed/stand-up bed range and a much wider offering, including bariatric beds, standing frames, and physiotherapy rehabilitation couches, we are well positioned to accommodate a varied client base and their needs.”
The partnerships in the business bring in skillsets including sales and marketing, regulatory, distribution, design and manufacture, and, importantly for the UK market, a clinical input.
Stuart Barrow is the clinical director of ISKOmed UK.
“Stuart being a qualified occupational therapist for almost 25 years with an extensive background in social services and private equipment and adaptations was the perfect fit for our UK company,” Greg continued. “We are delighted to have him recently join us as our clinical director.”
Stuart continues to run Promoting Independence, a bespoke clinical practice that runs the Occupational Therapy Adaptation Conference (OTAC), making his day-to-day clinical skills and operational management a perfect fit for the business.
Being a BHTA member can give firms access to important, relevant, and timely information regarding supply chain issues.
Greg explained: “The ongoing issues facing the global economy have an impact on everyone’s daily life in some way, whether it’s cost of living, energy costs, or sourcing components.
“Our supply chain issues seem somewhat less with German manufacturing. We enjoy quick delivery times and fortunately do not suffer the well documented issues that shipping freight can be subjected too from the Far East.
“I believe that the BHTA support offered to the membership is vital where logistics is being affected, and, as a member previously, have utilised their knowledge in this area to assist the business.”
ISKOmed UK will be attending all of the remaining OTAC events in 2024 and throughout 2025. The firm is also the headliner sponsor of the Moving and Handling Conference in October 2025.
Greg added: “We are also greatly looking forward to the BHTA Awards Dinner 2024 in November, giving us a great opportunity to meet with colleagues and partners in the industry.”
Greg said that there could be more new products from ISKOmed UK very soon.
Greg has highlighted the benefits of being a member of the BHTA, which importantly includes being part of an association that represents companies’ interests and concerns and lobbies for change.
“As a recent new member and having been a member in my previous organisation, I wanted ISKOmed UK to enjoy the full benefit from being part of the association and to be an active component within it,” Greg explained.
“When you enter a marketplace in your own right, it’s important to be supported by a body that represents the interests and concerns of the healthcare sector and one that can take the voice of its membership and lobby for change on their behalf. The BHTA is that industry recognised association and, for the healthcare sector, the voice that is needed.
“Our first Section meeting is being kindly hosted by Medstrom on the 9th of October. I am personally looking forward to meeting my peers and offering relevant input as required.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The British Healthcare Trades Association (BHTA) has welcomed Manfred Sauer UK as a new member. Manfred Sauer UK is a specialist in continence management systems. Its high-quality and innovative products are often designed by end-users and healthcare professionals.
The BHTA recently caught up with Carol Hutching, Nursing Services Manager at Manfred Sauer UK, to learn more about her extensive background in nursing, all about Manfred Sauer UK and Manfred Sauer Care, and the value of BHTA membership.
Carol Hutchings is the nursing services manager at Manfred Sauer UK. She joined the company in November 2018 and has previously worked as a nurse specialist within other commercial companies. She, therefore, has a good understanding of the commercial world, but ultimately it is her patients who come first and finding the best solutions for them is foremost.
Carol began training as a nurse in September 1984 at what was then the Barking, Havering & Brentwood School of Nursing. Based at Harold Wood Hospital, Carol has fond memories of her training there and her subsequent position as a staff nurse on an acute medical ward. Carol remembers the hospital as a friendly and fun place to work. Everyone pulled together and supported each other, and the training was such that they learned ‘on the go’. Teaching and supervision were second to none, so she knew right from the start that nursing was the right pathway to follow.
Carol got married during her second year of training and had her first daughter three years later but has continued with her nursing throughout.
In 1996, by which time she was at a different hospital, Carol was feeling a bit disillusioned with the way things were managed on the wards and decided it was time to try something different. She applied for her first commercial nursing position, and, although surprised at the time, she got offered the post.
She has not looked back.
Carol enthuses: “To steal a phrase from my friend and colleague, Tracy, I feel that my job with Manfred Sauer is my ‘forever job’ and that I will be with the company until it either puts me out to grass or I give in to retirement.”
Carol says: “In spite of Manfred Sauer UK being established for over 25 years ago, many people are still unaware that Manfred Sauer is a real person. Not only that, he is an absolute inspiration!”
Manfred was born in Germany in 1944. At the age of 19 in the UK, he had a diving accident resulting in a spinal cord injury. He has had tetraplegia since 1963, and he underwent his rehabilitation at the Stoke Mandeville Spinal Unit in the days of its founder, Sir Ludwig Guttmann.
Following his accident, he noticed a real gap in continence management and a lack of options available. As a result, in 1965, he began to develop and market condom urinals or urinary sheaths. In 1976, he launched Manfred Sauer GmbH, which is now a firmly established business enjoying a large share in the rehabilitation marketplace for continence systems in Europe and an ever-growing market share in mainstream continence management in the UK.
Thanks to the insight of Manfred back in the 1960s, Manfred Sauer UK is also now well known in the continence market. The company seeks to offer high-quality, innovative products, which are often designed by end-users and healthcare professionals.
Manfred Sauer UK is based in Northampton and is the UK distributor for the Manfred Sauer product portfolio, offering users a diverse and extensive choice. The products are manufactured in Germany.
“They undergo rigorous testing before they are released into the marketplace, as we believe it is vital to get things right from the start,” adds Carol. “We offer more choices in urinary sheath sizes than any other manufacturer; leg bags with unique features and benefits which make a difference; Nephsys, a specially designed Nephrostomy system that can be worn around the waist; and more.”
Manfred Sauer Care is the company’s home delivery and nursing service division. It offers a personal service with professional care. This is delivered by a friendly and knowledgeable team that takes time to listen and understand.
“We not only offer a prescription home delivery service, but one that puts the needs of the user first,” Carol says. “We pride ourselves in the fact that we take time to ensure every order is managed with sensitivity, care and, understanding.”
The service offers a swift and efficient delivery to a chosen address on a day that suits. Personalised product customisation is available.
Manfred Sauer Care also supplies all manufacturers’ products, holding a comprehensive range to enable it to fulfil all prescriptions promptly. It accepts prescriptions by electronic prescription service, and a Popular Standing Order Service is available.
Manfred Sauer Care will dispense any brand of continence, stoma, and woundcare product available on NHS prescription, direct to the patient.
In recent years, Manfred Sauer UK has expanded significantly, as Carol explains: “We are known as a company that provides innovative products or products with a difference. We have the Bendi bag, designed specifically for wheelchair users, and the NephSys system for people struggling with the management of their nephrostomy/s.
“With the popularity of such products, our business has grown substantially over recent years. As a result, we have expanded, and we run our business over two units instead of the one, as we did for years.
“Our nursing team is growing, and our prescription team are seeing an ever-increasing number of referrals to our service.”
Manfred Sauer UK has recently joined the BHTA. As the company has a small team, one of the main benefits of becoming a BHTA member is being part of a larger industry community.
Carol says: “We are faced with constant challenges, such as trying to keep up with the impact of the Part IX consultation and changes in regulations. We hope that being a part of the community will strengthen our business relationships and increase our knowledge and understanding of industry changing events. We very much look forward to working together.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The British Healthcare Trades Association (BHTA) has welcomed ProSys International as a new member. ProSys International designs, develops, and manufactures a range of clinical supplies and medical devices for acute and secondary care environments.
The BHTA recently caught up with Gill Sims, Clinical & Commercial Director at ProSys International, to discover more about the firm, the value of being a BHTA member, and difficulties keeping up with the latest regulations.
Gill enjoyed a successful career in medical device sales for over 30 years. She has previously worked in the stoma, urology, wound, and obstetrics and gynaecology markets.
Gill recently joined ProSys International to support the firm’s vision and business development strategy in expanding its bowel management, pressure area care, and infection control portfolio in both primary and secondary care environments.
“As a registered nurse I am passionate in supporting healthcare professionals with best practice solutions to support and overcome the challenges faced in today’s clinical and home care settings,” Gill enthused. “Providing products and educational services to enable care of the highest standard is our goal and we are building a respected team to spread our reach and support at grass roots.”
Gill says that contributing to the development of exciting new products in the pipeline in a dynamic environment is incredibly rewarding. ProSys International’s overall goal is to deliver high-quality and cost-effective solutions, which involves multidisciplinary professionals supporting the firm’s projects from the outset.
The company anticipates launching its latest development in early 2025. This will mark the start of a programme that sees the true development of the ProSys International brand over the next three years.
Prosys International is a micro SME founded in the late 1990s by Graham Steer. As a mechanical and bioengineer, Graham grew the business with a focus on the design, development, and manufacturing of medical devices.
The company developed a range of products to assist in the management of highly infectious bodily fluids based upon super absorbent systems, and this subsequently led to the development of the Secco Faecal Management system. The Secco Faecal Management System Secco Protect™ is an easy-to-use system that reduces skin breakdown and pressure ulcer development, while preventing cross contamination. With its unique super absorbency technology, it contains spillages and odours as well as maintains patient dignity.
“Most recently a range of pressure relieving devices were added to the product portfolio, and this addition will be a focus for the business as we move in a new strategic direction,” Gill adds.
The ProSys International range of products are sold via a range of distribution channels including the NHS Supply Chain.
Gill explains that, for a small team, it is difficult to keep up to date with the latest regulations, as resources are stretched.
She says: “For any size organisation the trials and tribulations of endeavouring to comply with both regulatory and voluntary requirements in the 21st Century is like ‘pushing water uphill’, but with the added issue of reduced resources in a company the size of ProSys our small team can be stretched, regulatory compliance is without a doubt our biggest challenge ahead.
“Barry Holland, Regulatory Affairs Manager for the company, explains that the two main adverse events in recent history that caused most disruption within the compliance field have been the PIP Breast Implant Scandal of 2010 and Brexit in 2020.
“Regulations have been strengthened (and lengthened), Notified Bodies are now relying on State-of-the-Art obligations with typical guidelines such as MEDDEVs (although most don’t have any legal status), and now, if we’re lucky enough to sell our medical devices into Europe, our costs to comply with both the EU Medical Devices Regulations 2017/745 and the UK Medical Devices Regulations 2002 have doubled.
“Politicians continually say that “red tape” will be reduced, but unfortunately this never happens! Government Quangos continue to publish commitments that micro businesses and SMEs be given a “light touch” approach, but again we are yet to see this happen.
“The challenges for medical device compliance have never been tougher.”
Gill says that joining the BHTA as a member will help give ProSys International a collective voice. The BHTA can also provide valuable support and guidance in overcoming some of these challenges.
There are many benefits to becoming BHTA member. For Gill, the most value comes from regulatory support, networking opportunities, educational sessions, being part of a collective voice, and aligning with the BHTA Code of Practice.
Gill comments: “Joining the BHTA was a no-brainer for me, having worked for several member companies in the past, I have enjoyed the networking opportunities, educational events, and the collaborative approach to our industry challenges.
“The BHTA Code of Practice aligns so well with the ProSys mission and values and reflects a philosophy of care and support, which is very much at the forefront of all our activities.
“I am so looking forward to meeting with the Section members in the coming months and engaging in discussions that enhance quality of life for our customers whilst developing and growing our respective businesses.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The British Healthcare Trades Association (BHTA) has welcomed LendoCare as a new member. LendoCare’s goal is to simplify access to at-home medical equipment through rental models.
The BHTA recently caught up with Solomia Boretska, CEO/Co-founder of LendoCare, to find out more about the firm, its plans for the future, and how the BHTA can support with key issues.
Solomia is a neuroscientist by background, as she explained: “I volunteered with the MND Association during my studies and saw firsthand the difficulty of accessing equipment across the UK.”
That is when LendoCare was born.
“I started the business with my brother and co-founder to tackle the lack of digitalisation in the equipment hire process for customers,” Solomia continued.
LendoCare is building the digital equipment hire service for the UK, offering customers easy availability and a booking platform. Its mission is to tackle the postcode lottery of care by providing affordable healthcare equipment services at a national scale. Looking ahead, LendoCare plans to expand into the electric wheelchair and scooter sector.
LendoCare decided to become a BHTA member for several reasons.
As LendoCare expands, it is seeking support with medical device registration regulations and supply chain support. These are two areas where the BHTA can offer expert guidance.
LendoCare also wants to learn from other BHTA members in the space and receive up-to-date and relevant regulatory information.
Solomia added: “I’m keen to attend some in person events as well as Section meetings.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The British Healthcare Trades Association (BHTA) has recently welcomed Stairlift Recycling Ltd as a new member.
Stairlift Recycling Ltd removes used stairlifts and refurbishes them before offering them to those in need at reduced rates. Its refurbished stairlifts come with a lifetime warranty, providing customers with peace of mind.
The company’s mission is to enhance independent living by significantly lowering the cost of mobility equipment and reducing environmental waste.
Established in 2013, Stairlift Recycling Ltd has provided affordable, high-quality stairlifts for over 10 years. Its services help bridge the gap for individuals in need of affordable mobility solutions.
Stairlift Recycling Ltd has managed to overcome challenges around people being wary of purchasing second-hand or refurbished equipment.
The company explains: “The refurbished stairlift market is highly specialised and aimed at people with mobility issues, often the elderly or disabled. Raising awareness about the benefits of reconditioned stairlifts can be difficult, especially when new stairlifts by the big companies dominate the market.
“Consumers are wary of purchasing second-hand or refurbished equipment, especially devices like stairlifts. Overcoming these concerns through marketing and advertising is crucial.”
Stairlift Recycling Ltd decided to become a BHTA member to ensure it aligns with high industry standards and gains additional credibility in the healthcare market.
The BHTA is known for its strict Code of Practice, which is approved by the Chartered Trading Standards Institute (CTSI). By joining the BHTA, Stairlift Recycling Ltd can demonstrate its commitment to ethical business practices, customer protection, and safety standards.
Stairlift Recycling Ltd adds: “Being part of the BHTA helps us to reassure customers that our products and services meet rigorous quality and safety criteria. It also enhances trust, particularly for potential customers who are hesitant about purchasing refurbished mobility equipment.
“Moreover, BHTA membership allows us to network with other reputable healthcare businesses and stay informed on industry trends and regulations.”
The company is looking forward to attending any upcoming BHTA Regional Networking Lunches alongside BHTA Stairlifts and Access Section Meetings.
Looking ahead, Stairlift Recycling Ltd will expand its operations through localised hubs nationwide, which will help the firm deliver faster installation and maintenance services. Another focus is on creating job opportunities for veterans, helping ex-servicemen and women reintegrate into society by employing them in various roles within the company.
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The British Healthcare Trades Association (BHTA) has responded to Lord Darzi’s recent independent investigation into the current performance of the NHS across England and the challenges facing the healthcare system.
The report outlines areas where the NHS is performing poorly, the key reasons behind this, and some suggestions to bring the NHS back to peak performance.
Reacting to the report, David Stockdale, Chief Executive of the BHTA, commented: “Lord Darzi’s report offers a refreshing perspective as the Government faces the realities of the NHS’s current challenges. The health service, its employees, and suppliers have been undervalued and underused for too long, which this report fully acknowledges.
“I’m particularly pleased to see the stated shift in focus from hospitals to community care. The BHTA stands ready and willing to support the NHS in accelerating this transition, as our members provide both the innovations and local expertise needed to usher in a new era of healthcare in the UK.”
On 10 September 2024, the British Healthcare Trades Association (BHTA) hosted a Dementia Awareness Training session for its members.
The half-day event took place at the NSPCC National Training Centre in Leicester, and the training was delivered by Nadine from the Alzheimer’s Society.
The aim of the session was to enable staff who interact with customers, both on the phone and in person, to feel more confident and skilled in supporting customers with dementia.
Key learning outcomes were for staff to learn what dementia is and how to spot the signs and symptoms; understand how the symptoms of dementia can affect a person’s behaviour and communication; and learn practical ways to support people with dementia in a customer-facing environment.
The engaging training also touched on:
The training has received positive feedback from attending BHTA members.
Hayley Smith, Operations Manager for Wenman Healthcare, commented: “I thoroughly enjoyed this course, I would say it’s been one of the most useful and interesting training courses I have attended. The trainer was excellent and had a vast experience of working with dementia which showed during the training and shared her own experiences which really helped.
“I now feel much more confident when I go to assess someone living with a form of dementia, it’s almost made me want to campaign for The Alzheimer’s Society to get the word out there!”
Claudia Davies, Prosthetist at Opcare, enthused: “Me and my colleague Jess both found the training incredibly useful for our role. Nadine was a very good speaker. She did an excellent job, and the content and delivery were relevant and interesting.
“I am an educator in our company, and I’ll be putting forward a request to get this training included in our base training.
“The only downside was the long commute, so if there were any different closer locations in future that would be appreciated.”
This year, Cornwall Mobility, which provides high-quality services and equipment to people in South West England, has achieved an impressive milestone of being a British Healthcare Trades Association (BHTA) member for 15 years.
The BHTA caught up with Richard Breedon, Retail Manager at Cornwall Mobility, to learn about the charity’s biggest achievements over the last 15 years and why it has decided to stay a member for over a decade.
Cornwall Mobility has been established since 1983, providing high-quality services and equipment to people in the southwest. The charity started from a modest premises in Redruth before moving into a purpose-built facility at Treliske in 1994.
“Since then, we have developed into one of the largest mobility centres in the UK,” Richard said.
“We work with a network of mobility centres across the country to provide the best solutions for driving assessment tuition, healthcare, and adaptations supported in our workshops. We also work with health care professionals in hospital care organisations, general practice, and social services.”
As an independent charity, Cornwall Mobility is completely impartial in its choice of suppliers of services or equipment. It always assesses the needs of its clients first before suggesting a solution to meet their particular circumstances.
The main services that Cornwall Mobility Centre provides include:
Over the past 15 years, Cornwall Mobility had accomplished a lot and certainly has a great deal to be proud of. Below are some of the charity’s most impressive feats from over the years.
Cornwall Mobility provides all-terrain wheelchairs (AKA sand chairs) for the public to use for free on many of the beaches across Cornwall. This has been made possible by the charity partnering with disAbility Cornwall & Isles of Scilly, with funding by Cornwall Council, and working with a diverse range of coastal charities and businesses.
Through working with Driving Mobility and the BHTA, Cornwall Mobility got involved in the creation of the PWMS retailer training scheme. This is now run with the support of the Department for Transport throughout England. Cornwall Mobility provides courses throughout the year in Cornwall. An upcoming course is available at the charity’s Exter site on 20September 2024.
Additionally, Cornwall Mobility contributed to several key stages of the European ADAPT project (Assistive Devices for empowering disAbled People with Technologies) with partners from across England and France. This project ran from 2017 to 2022.
The charity has also expanded its offering by opening two satellite premises in Exter and Plymouth. There is an open day at its Exeter site on the 14 August, where anyone is welcome to attend.
More recently, the charity has provided Cornwall Airport’s new fleet of wheelchairs; worked with Coodes Solicitors, which has sponsored its Truro Open Day; worked with Vision Zero and Devon & Cornwall Police while presenting ‘Drive Safer for Longer’ talks in the community (ongoing project); provided a new fleet of wheelchairs to the Steamship Group in Penzance; and worked with Humans Cornwall to provide ‘Personal Care Packs’ and equipment.
When asked about why the charity has stayed a member for 15 years and the value of BHTA membership, Richard responded: “Membership really highlights that our customers have the extra assurance that we will always go far beyond the normal requirements of a business.
“BHTA membership also highlights that we are trustworthy and have our clients’ best interests at heart at all times.
“Adhering to the BHTA Code of Practice, as well as that of our own, fully supports our commitment to client satisfaction and excellent customer service.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
Recently, the British Healthcare Trades Association (BHTA) held its inaugural regional networking event in Kent for members, which proved to be a success.
The free event took place on 4 July at The Wharf in Dartford, where attendees enjoyed a complementary buffet lunch. All BHTA member companies and staff were invited.
The informal networking lunch was a chance for members to network across all BHTA Sections, so attendees could reconnect with familiar faces and meet new people they may not ordinarily have a chance to connect with.
Here’s what attendees had to say about the regional networking event:
Oksana Pylypenko, Project Production Manager from John Florence, said it was a “fantastic networking lunch”.
Gary Tidman, Director of Only Lifts, remarked: “All in all I thought it was great, having recently attended a joint section meeting it was all very familiar faces. There seemed to be good engagement cross industry as well. Would definitely attend another.”
Kylie Evans, Head of Mobility at Mark Bates, commented: “What a fantastic regional networking lunch organised by the British Healthcare Trades Association – hopefully the first of many. It was great meeting with other companies within the industry and discussing our different experiences. Myself and Danny Bates had a great time.”
The next BHTA regional networking event is taking place in the West Midlands at The Hatton Arms on 5 September from 12pm-2pm, where attendees can enjoy a free buffet lunch. Members can register for tickets here.
At the recent British Healthcare Trades Association (BHTA) Conference 2024, Laura Squire, Chief Healthcare Quality & Access Officer at Medicines and Healthcare products Regulatory Agency (MHRA), discussed where UK medical device regulation is at now and what the future looks like.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
Laura began by explaining the MHRA’s purpose in delivering the future regulatory framework of medical devices in the UK. Its goal is to deliver a robust and leading regulatory framework that prioritises patient and public safety. In delivering this regulatory framework, the MHRA’s chief goals are to deliver:
The new regulatory framework has been implemented via a series of Statutory Instruments (SIs), Laura explained. Further details are in the slide below.
Laura also provided details of where MHRA is at now with UK medical devices regulation and plans for 2024-2025. The slides below provide more information.
“We’re trying to be more transparent about our timescales,” Laura commented. “But it’s very difficult to be transparent about timescales when you’re doing legislative work, because there are certain things that are not within our gift in terms of timescales.”
A key point from Laura’ presentation was around international recognition. MHRA recently published a statement of policy intent, which outlined MHRA’s intention to recognise medical device approvals from Australia, the EU, Canada, and USA. It contained further details for the access routes depending on the device type, class, and prior approval.
“We are also working actively with Japan to bring them into the international recognition,” added Laura. “It’s slightly more complex there because of the population and understanding how they apply some of the international standards, but there is no doubt that Japan is a rigorous regulator, so we would trust it.
“We’re calling these comparable regulators, because I don’t like the phrase ‘trust’. It implies we don’t trust everybody else, and we do trust quite a lot of other regulators. It’s about the practicalities of making it work. At the moment, these countries are the ones that we think we can get to work, and we’ve worked with all these countries to try to design the framework.”
MHRA is testing the proposed framework in collaboration with industry and approved bodies, using a range of devices with existing approvals from these countries. Market access via international recognition would only be formally granted once the future core regulations are in force, Laura explained. The proposed framework may be updated based on these activities.
At the recent British Healthcare Trades Association (BHTA) Conference 2024, Barney Willis, Deputy Head of Life Sciences at the Department for Business and Trade (DBT), explained how DBT provides practical support to UK medtech SMEs with exporting.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
Barney began by explaining what the DBT does. The department brings together business and trade in a single department. Export and investment are the two pillars of the department. DBT also opens up new markets for businesses by removing barriers and negotiating trade deals, which can lead to practical opportunities opening up.
Barney provided some insightful UK medtech sector statistics. See them in the slide below.
Despite the UK having an innovative, productive, and fast-growing medtech sector, UK medtech exports are low relative to international comparators, he said. The UK imports more than it exports.
The key point from Barney’s presentation is that the DBT provides practical advice and support to SMEs to help them grow and export, which involves non-stop engagement. Barney outlined some of the practical support available to SMEs in the slide below.
Barney said: “We will competitively recruit between 10 and 14 companies, which will be UK SMEs that have got something competitive that we think has a chance of being successful in an overseas market.
“For example, I’m flying to Saudi Arabia with about 10 companies, which we recruited from across the assistive tech and medtech sectors, and we will use the convening power of the British Embassy to get them into rooms they wouldn’t otherwise get into.”
Importantly for SMEs, DBT has a network of international trade advisers across the south, midlands, and north of England, Barney explained. These advisers provide businesses with free and impartial export support. Additionally, they can help firms develop their export strategy, access masterclasses, link firms to specialist export advisers, and help firms make the most of DBT’s global network so they can grow their business overseas.
DBT’s overseas network spans over 100 markets with a global reach in more than 170 countries. These include Canada, the US, Germany, UAE, Japan, Spain, New Zealand, China, and more.
Barney added: “DBT has embedded staff in most of the markets you’re likely to care about, and certainly the large ones. These will be, in many cases, specialists who know the sector in their country. They will often be locally engaged.”
At the recent British Healthcare Trades Association (BHTA) Conference 2024, Mark Chapman, Interim Director Medical Technology Digital & Diagnostics at the National Institute for Health and Care Excellence (NICE), delved into the NICE healthtech assessment lifecycle approach and innovative vs iterative healthcare products.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
Mark began by explaining how NICE is transforming by developing guidance that is more:
Progress has been made on these changes, which are detailed on the slide below.
An important topic from Mark’s presentation was around whether products are innovative or iterative.
Mark said: “A product starts off massively transformative and innovative. Then, over time it iterates. By the end, it’s got a lot of additional items added to it. It’s the additional items that make it different to the predecessor, but you wouldn’t class it massively as innovative.
“The reason why it’s important to think about this is, for so many years, we’ve tried to polish what may just be another pair of shoes and convinced someone that they’re the better thing to have. That might be the case, but it’s not always the case.”
The MedTech Strategy touches on the right product for the right patient at the right time.
“When we think about innovation without differentiation, that’s what holds us back,” Mark explained. “Far too often, innovation has gone into the system, and the next innovation has come along. You don’t know whether the first one was the game-changer or the second one was the game-changer, because we’ve rarely done any full assessments.
“That’s what we want to shape NICE to be looking at more intentionally.”
With this in mind, NICE has introduced and refreshed its topic prioritisation programme. This allows NICE to select the right technologies for consideration of a NICE assessment, dependent on the evidence, availability, the access to it, and the need in the health and social care system.
Then, through various stages, NICE will start looking at how much this would cost, the system impact for that investment, population impact for that investment, and these may be cost saving. Whereas historically in the healthtech programme, everything was forced into proving cost saving.
“Once a product has been selected, we’ll embark upon a health technology assessment,” continued Mark. “A health technology assessment is a collective term that describes a set of methods and approaches to assess the value proposition of a technology.”
A key point from Mark’s presentation was around NICE’s life cycle approach to healthtech assessments. See the slide below for further details.
Where possible, real-world evidence (RWE) will be prioritised for late-stage healthtech assessments, added Mark.
At the recent British Healthcare Trades Association (BHTA) Conference 2024, Andrew New, CEO of NHS Supply Chain, explored how NHS Supply Chain will change over the next five years to make it better to work in and with.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
Andrew explained the fundamentals of the organisation: “NHS Supply Chain exists to try to simplify the way marketplaces work; to try to engage trusts on a collective basis so we get consistent decision-making, and it’s not sporadic as it has been historically; and to make these markets work more effectively.
“We’ve been doing a lot over the last year or so to reorganise the way we work at the same time as continuing to run very fast in delivering the benefits that all of our supply base offer to the NHS. None of this can be done without the whole system working together, and that’s a key principle of everything we’ve done.”
Andrew highlighted that NHS Supply Chain initially started out doing a fantastic job of focusing on what it was asked to do but not doing the job the NHS needs in the future. The slide below details some of the areas where NHS Supply Chain has built on solid foundations to ensure it is fit for the future.
In one year, NHS Supply Chain and suppliers have achieved a lot, Andrew explained. Headline achievements include:
He underlined that there is an opportunity to save £40 million across the NHS, but there is a backlog of work, and it requires clinical intervention.
Andrew shared NHS Supply Chain’s strategy and corporate priorities. See the slide below for further details.
One key point from Andrew’s presentation was around NHS Supply Chain’s work to enhance the clinical voice across the organisation.
“We need to enhance that voice both in the conversations we have with trusts as well as with suppliers,” he continued. “We’ve brought in a new national clinical director, Michelle Johnson, who is bringing together a clinical community to make sure we have clinically led decision-making everywhere. That is hugely valuable to us as an organisation, and we’re already seeing the benefits.”
NHS Supply Chain is going to clinically segment products in terms of priority, importance, value, and making a difference in healthcare outcomes. The organisation also wants to simplify prices so that there are not 10 different prices for the same thing.
See the slides below for an outline on the work NHS Supply Chain is doing to transform its commercial capabilities, strengthen the supply chain, and improve processes.
Are you a visionary leader with a passion for healthcare? Do you want to drive change and influence the future of the UK’s health and social care systems? The British Healthcare Trades Association (BHTA) is seeking two dynamic and forward-thinking individuals to join our esteemed Board of Directors.
About Us: The BHTA is the UK’s oldest and largest healthcare association, representing over 400 companies in the healthcare and assistive technology sectors. Our mission is to champion our members, protect consumers, shape policy, and drive standards.
Why join us?
What we’re looking for:
Your responsibilities:
How to apply:
View the job description here and the Terms of Reference here
If you are ready to make a difference and lead the future of healthcare trade in the UK, we want to hear from you!
Please submit your CV and a cover letter detailing your experience, expertise, and vision for the BHTA to david.stockdale@bhta.com by Friday 5 July 2024.
For an informal discussion about the role, please contact David Stockdale, CEO, in the first instance. Applications must come from individuals currently working within a BHTA member organisation.
Timeline:
The closing date for applications is Friday 5 July 2024
Interviews will be held across July and August, with a recommendation being made to the November board meeting and to be approved at the December 2024 AGM.
It is anticipated that new Directors would start their role in January 2025.
At the recent British Healthcare Trades Association (BHTA) Conference 2024, Fiona Hilton, Director of Commercial Best Practice & Engagement for NHS England, discussed The Procurement Act 2023 and the Strategic Framework for NHS Commercial.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
Fiona highlighted the NHS Commercial portfolio and how it all links together. This revolves around four central initiatives: the NHS Central Commercial Function (CCF) service offers, the Commercial Efficiencies Programme, the Procurement Act, and the Strategic Framework for NHS Commercial. See the slide below for further details.
“We’re trying to link the NHS much more into how the whole of central commercial government works, so that we can collaborate and engage with some of the standard practices that are already in place,” Fiona said.
One key point from Fiona’s presentation is that healthcare procurement is set to transform in 2024 with the introduction of two new procurement regimes: the Procurement Act 2023 and the Provider Selection Regime (PSR).
Fiona emphasised that the NHS believes that the Procurement Act 2023 is key to transforming procurement in the medtech sector. The Act will go live on 28 October 2024.
“We believe that the Procurement Act is a fundamental catalyst to enable change,” added Fiona. “It’s really key for us to be able to establish what we want to do on innovation, working with SMEs, and enabling greater transparency with our suppliers.”
The Procurement Act 2023, she said, will introduce a new competitive and flexible procedure that will enable the NHS to work innovatively and faster with suppliers. It simplifies the regulations that govern public procurement and promises increased commercial flexibility.
Additionally, within the Act, the Competitive Flexible Procedure will allow contracting authorities to design processes that best suit their needs, rather than follow suboptimal standardised procedures.
Importantly, Fiona stressed that the Act will give the NHS an enhanced to take into account poor performance suppliers and the potential debarment of those that do not improve, which will help the NHS improve outcomes.
Additionally, Fiona encouraged medtech suppliers to become familiar with the PSR, which launched in January 2024. It represents a new set of rules governing healthcare services in England. The PSR exempts healthcare contracts from the formal public procurement regime. Fiona added that the regime enables a more flexible, proportionate process when awarding healthcare contracts.
Another important topic from the presentation was around the Strategic Framework for NHS Commercial, which aims to be globally renowned, supporting the delivery of the world-class Commercial Function in healthcare, in patient care, and in outcomes. See the slide below for more information.
Fiona explained: “The Strategic Framework was put together originally in order to be able to support the whole of commercial healthcare for outcomes, not just about value for money upfront. It was about benefitting the whole of the life cycle, and the outcomes across all of commercial.”
At the recent British Healthcare Trades Association (BHTA) Conference 2024, David Lawson, Director of MedTech for the Department of Health and Social Care (DHSC), presented an engaging presentation on value-based procurement and a MedTech Strategy update.
The BHTA Conference 2024 focused on the UK healthtech landscape over the next five years. It was a chance for BHTA members to hear from senior government and NHS speakers about how the changes made today will impact the future of the health service.
In his presentation, David remarked that it is a very active time in the procurement and medtech sectors, and that there is a genuine desire for DHSC to engage with industry, including BHTA members, to ensure its proposals are grounded and well thought-out.
David reflected on the ‘The medical technology strategy: one year on’ report, which reflects on the MedTech Strategy and provides an update on where the medtech sector is headed. Since the MedTech Strategy was published, there are multiple medtech initiatives in flight, such as the Innovative Devices Access Pathway (IDAP).
One of the central themes in David’s discussion was around value-based procurement. He stressed that the lowest price does not always equal best value.
He also highlighted some of the key problems DHSC is trying to solve in the medtech sector. See the slide below.
One issue David particularly emphasised with evaluating procurement is around validating evidence submitted by suppliers.
He said: “Can we believe the claims from industry? How do we validate that? How do we trust the information? Having good data is part of that validation process.
“At the moment, there’s an absence of clarity in terms of validation. That leads to a lack of consistency. Different trusts across the country apply value-based procurement assessment of medtech in different ways. There isn’t a methodology to set a common way of doing this. That makes it inefficient for everyone.
“It’s quite difficult to do validation on medtech, because medtech doesn’t stand still. A product is developed, it then gets iterated, more data is collected, and more evidence is collected. It’s quite hard to make a validation process that’s dynamic and that reflects the way that medtech operates, alongside the scope and scale of medtech.”
David underlined that it may take a while for DHSC to come up with an appropriate, robust, and sustainable process for validating medtech.
In addition, David outlined potential options to move work forward. See the slide below.
David said: “This question about validation of evidence, our thinking at the moment is that we need a system solution. We need some sort of portal where suppliers can submit their information, there’s a validation process, and it can be updated.”
Moreover, David underlined some of the key issues DHSC is trying to iron out to make the medtech sector work more seamlessly. See the slide below.
“From a UK perspective, the majority of our medtech industry is SME-based, so we need to make sure that at a government level and a system level that we are doing everything we can to support SMEs, not make it harder,” he commented.
The British Healthcare Trades Association (BHTA) recently hosted another successful conference that brought together healthcare leaders and suppliers to discuss how the changes made today will impact the future of the health service.
The sellout BHTA Conference 2024, ‘Health Tech in the UK: The next 5 years’, took place at the Northampton Town Centre Hotel on 21 May and was sponsored by Verlingue.
Boasting an impressive roster of key government and NHS speakers, engaging presentations throughout the day included topics on the MedTech Strategy one year on, the Procurement Act 2023, late-stage medical device assessments, practical export support for UK SMEs, UK medical device regulation changes, and much more.
Attendees had the chance to ask the speakers important questions during two Q&A panel discussions throughout the day.
The conference kicked off with a welcome from BHTA CEO David Stockdale, who highlighted some of the BHTA’s successful campaigns, how the BHTA lobbies to government to ensure its members’ voices are heard, and an overview of the BHTA Conference 2024.
Next, Lord Markham, Parliamentary Under-Secretary from the Department of Health and Social Care (DHSC), shared his opening remarks. Lord Markham outlined that the UK has massive potential to transform the medtech landscape over the next five years and highlighted relevant and successful government initiatives like Innovative Devices Access Pathway (IDAP), the MedTech Strategy, and late-stage medtech assessments.
David Lawson, Director of MedTech for DHSC, delivered a presentation titled ‘Value Not Cost’. He discussed the ‘The medical technology strategy: one year on’ report, the issues DHSC is trying to solve when it comes to the medtech sector, and value-based procurement.
Fiona Hilton, Director of Commercial Best Practice & Engagement for NHS England, discussed the Strategic Framework for NHS Commercial. Her presentation delved into how the Procurement Act 2023 will significantly change how the NHS works with suppliers and the Strategic Framework for NHS Commercial.
Andrew New, CEO of NHS Supply Chain, presented ‘One Year On – More to Come’. He talked about how NHS Supply Chain will change over the next five years to make it better to work with, and how it aims to enable an optimised, resilient, and sustainable supply chain.
Mark Chapman, Interim Director Medical Technology Digital & Diagnostics at NICE, commenced the afternoon presentations. His presentation was titled ‘NICE HealthTech Assessment: Focus on What Matters Most’. Mark explained the NICE HealthTech Assessment lifecycle approach and late-stage medical device assessments.
Barney Willis, Deputy Head of Life Sciences for the Department for Business and Trade (DBT), explained how DBT provides practical support to UK medtech SMEs with exporting. Barney provided an insight into how DBT promotes innovative UK medtech companies in key global export markets.
Before the closing remarks, Laura Squire, Chief Healthcare Quality & Access Officer at Medicines and Healthcare products Regulatory Agency (MHRA), delivered the final BHTA Conference 2024 presentation. Her talk, ‘How Regulation of Medical Devices in the UK is Changing’ explored where UK medical device regulation is at now and what the future looks like, alongside international recognition of medical devices.
Positive feedback from the day included:
“An excellent set of speakers and some thought-provoking questions. Given the make-up of BHTA membership, it was good to see several references to the importance of SME business from the speakers.”
“A very good event with really good Q&A sessions. The speakers and the topics they covered should have been of real value to members. I always go looking for 3 or 4 golden nuggets at a day like this, and there were several.”
“It was a really informative day, great speakers, content, location, room, and lunch.”
“It was obvious from how well it went that a lot of work has gone into it, so I hope all the team involved are justifiably proud of the day.”
The Medicines and Healthcare products Regulatory Agency (MHRA) published a statement of policy intent for international recognition of medical devices on 21 May 2024.
Entitled ‘Statement of policy intent: international recognition of medical devices’, it describes how the UK Government intends to recognise regulatory approvals from Australia, Canada, the European Union, and the United States of America depending on device type, class, and prior approval.
The MHRA continues to review the list of comparable regulator countries and is in active discussions with the Pharmaceuticals and Medical Devices Agency (PMDA) to explore the recognition of medical device approvals from Japan.
The MHRA’s statement of policy intent focuses on ensuring safe access to quality-assured medical devices and reducing the duplication of assessments by comparable regulators to enable resource to be focused on more innovative products for the benefit of patient health. This statement will also allow manufacturers to start considering whether their devices will be eligible for the proposed alternative routes to market.
The proposed framework is still in draft, and the final version would be integral with the future core regulations.
Dr Laura Squire, Chief Quality and Access Officer of the MHRA, said: “Today’s announcement is an important step forward towards a robust MedTech regulatory framework that prioritises patient safety, gives patients access to the medical devices they need and ensures the UK remains an attractive market for medical technology innovators.
“We will continue to work on how our intended policy on international recognition of medical devices will operate in practice. By sharing the draft policy now, we aim to give greater clarity about the MHRA’s future direction of making regulatory approvals simpler, where it is safe to do so. At the same time, we remain fully committed to the UKCA marking for medical devices.
“We continue to expand capacity in UK Approved Bodies and to work to ensure UKCA marking supports safe and earlier access to the most innovative and transformative medical products.”
To be eligible for the proposed framework, medical devices will need to:
The proposed framework would provide a certificate of international recognition that will grant devices access to the Great Britain market but would not provide a UKCA marking or UKCA certification. MHRA underlines that manufacturers of medical devices would still have the option to use the UKCA marking to place devices on the Great Britain market.
Mobility equipment supplier Dash Rehab has introduced two new power rollators to its range, the Dash 3 in 1 power rollator and Dash Ultra 3 in 1 power rollator.
Dash Rehab is part of RHealthcare, which was formed through the purchase of Remploy Healthcare. RHealthcare is a member of the British Healthcare Trades Association (BHTA).
Each power rollator is highly adaptive and supports varying needs, including nursing, rehabilitation, exercise, and travel, through a variety of functions. It can be a rollator, powered rollator, walker, wheelchair, or electric wheelchair.
The assistive devices are designed to support people who have trouble walking or are unable to walk long distances.
Both power rollators feature a compact collapsible frame and swing-away leg rests (these are also detachable on the Ultra model), which makes storage and travel easy and convenient. The rollators are designed to slide into a boot, onto a back seat, or in a luggage compartment on public transport.
In addition, the Dash and Dash Ultra 3 in 1 power rollators boast Bluetooth functionality. This enables the user to drive the power rollator using an app downloaded to a smart phone or tablet. This option combines Bluetooth connectivity with the rollator’s powered functions to drive the rollator away into a storage space, for example, or call it closer for ease and convenience.
Alongside Bluetooth connectivity, there are front and rear controls on both models. When driving, the user can select up to five gears for speeds between 0.7 to 3.7mph forward and 0.6 to 1.3mph in reverse by pressing the gear + or gear – buttons on the front control. The joystick is tilted for the direction of travel.
When the front control is working, the rear control automatically stops, and vice versa.
Moreover, the rear control on the hand grip provides power assist when used as a wheelchair or resistance when used as a rollator. The resistance mode (Gear: 01 to 03) prevents the wheels from turning too fast. If this happens, the anti-fall function kicks in and the autobrake is applied.
The power assisted mode (Gear: C1-C3) provides automatic power assistance to push and for ease when using the wheelchair function. Power assisted brakes aid this.
Both rollators are comfortable with a supportive seat with padded cushion and backrest.
The backrest and handlebar height are adjustable. The backrest can be reversed too, offering support and giving confidence when in rollator mode. Additionally, the large spacious shopping bag means there is plenty of room for shopping and essentials when users are out and about.
The Dash 3 in 1 power rollator weighs 18.6kg and is available in black. The Ultra model weighs 21.7kg and comes in white. Bother power rollators can support up to 100kg (15.7 stone).
When used as an electric wheelchair or in power assisted mode, the Dash 3 in 1 power rollator can travel between 7.4-12.4 miles on a single charge of the 6Ah/10Ah battery, powered by two 250W motors. The charge time is four-five hours.
The Ultra is more powerful and can travel up to 9.3 miles on a single charge of the 24V 10A battery, powered by a 24V 250W motor. The charge time is six hours.
To accelerate traceability of medical devices, NHS Supply Chain has launched a new policy on Data Standards for Supplier Product Coding.
The new policy means that medical devices and clinical consumables suppliers are to adopt globally recognised coding standards for product identification, preferably the GS1 Global Trade Item Number (GTIN).
NHS Supply Chain also requires medical devices to carry ‘Unique Device Identification’ (UDI) compliant barcode labels, which will carry scannable information relating to the production of the device, for example the expiry date and the serial or lot number.
There are two documents available to download on the NHS Supply Chain website relating to the new policy.
According to NHS Supply Chain, improving data on medical devices across the NHS system is a key contributor to improving patient safety through greater and more rapid traceability.
It says that, at the moment, medical device data is not routinely collected in a consistent manner or standardised digital format. Current processes are often paper-based and lack standardisation and validation, which means that tracing medical devices is time consuming and laborious and linking devices to patient outcomes difficult.
NHS Supply Chain’s vision is that a single scan from inventory management systems can be integrated to have many uses across the NHS.
The adoption of global standards, such as GS1, for product identification, enhances the traceability of medical devices and other products used in an episode of patient care. It also means that the clinical time required for product or patient recall is reduced.
The GS1 standards provide a common foundation and consistent format and enables the unique identification, capture, and sharing of information automatically. When data describing medical devices is captured electronically it can be easily associated with a patient and provide accurate information about which devices have been used in their care.
This electronic data capture for product forms part of the NHS England Scan4Safety programme methodology to capture data for person (patient and caregiver), product, place, and procedure.
Access to this data electronically in a standard format enables it to be interrogated and performance of medical devices can be monitored, patient outcomes measured, and any potential issues with devices can be identified faster and more easily allowing clinicians to intervene and if necessary, prevent harm before it happens.
The policy will also support NHS Supply Chain in improving the quality of its critical product data and increasing the number of GTINs it holds for medical products in its catalogue.
Experts from the BHTA First Aid Medical Equipment (FAME) and Defibrillator Section have worked together to agree on a suggested standard for cabinets that house public access Automated External Defibrillators (AEDs).
The guidance was put together because people were being supplied cabinets that weren’t suitable for the application. For instance, they didn’t have heaters in.
The BHTA FAME and Defibrillator Section came together along with leading manufacturers in the field to agree a proposed standard for the benefit of the user’s community to ensure that when they access a defibrillator in a cardiac arrest medical emergency that the defibrillator will have been kept in a suitable environment for its effective deployment, provided the serviceable items, such as pads, have been kept in date.
All public access defibrillators should be registered on the British Heart Foundation (BHF) Circuit and similar other charity websites, such as Webnos. When someone dials 999 in a cardiac arrest medical emergency, this means that ambulance services know where the nearest operational defibrillator is to guide the caller to its location and, if necessary, give the access code.
Download the BHTA guidance document as a PDF here.
Newlife, a national charity for disabled children, has published a new report, which reveals that a growing number of disabled children are being let down due to a lack of access to essential support and specialist equipment such as wheelchairs, buggies, beds, and car seats.
The report states that there has been a big increase in the number of disabled children in the UK over the last 10 years, but that local services are not robust or responsive enough to evolving pressures. This includes a holistic and proactive approach to equipment provision.
Newlife’s report underlines that disabled children and their families are navigating a “failing system” that is too often leaving them without the specialist equipment and support they urgently need.
Four key themes have emerged: a lack of leadership at government level, a shortage of suitable professionals, increasing waiting times for assessments, and insufficient equipment budgets.
One key finding from the report is that 75 percent of professionals are concerned there are children living without essential equipment, with only 39 percent of families feeling their child has all the specialist equipment they need.
Moreover, local services provided less specialist equipment in 2022/23 than the previous year, with 41 percent cutting their equipment budgets.
In addition, there has been a 27 percent increase in disabled children waiting for assessment over the last two years – nearly a quarter of local authorities have waiting lists over one year, with some exceeding three.
Based on the report’s findings, Newlife is urging policymakers to implement a series of cost-effective recommendations to break these barriers and secure a brighter future for disabled children.
The charity has made the following recommendations to policymakers:
The British Healthcare Trades Association (BHTA) supports Newlife’s key recommendations to policymakers and urges the next government to implement them in full.
Hayley Phillippault, Chair of BHTA Children’s Equipment Section, said: “Obtaining the right equipment at the right time has been demonstrated time and again to offer huge health, economic and wellbeing benefits to disabled children, their families and UK taxpayers.
“The forthcoming UK general election presents an opportunity to transform the life chances of these children and save vital NHS resources through the adoption of the six recommendations put forward in Newlife’s policy manifesto. The BHTA Children’s Equipment Section fully support these recommendations and urge the next government to implement them in full.”
Mobility equipment supplier Dash Rehab has introduced the new Dashi Lite to its powerchair range. It is lightweight with a foldable aluminium frame and is designed for indoor and outdoor use.
Dash Rehab is part of RHealthcare, which was formed through the purchase of Remploy Healthcare. RHealthcare is a member of the British Healthcare Trades Association (BHTA).
The Dashi Lite features extra-wide tyres with anti-skid technology, hill hold assist up to nine degrees, and a reliable electromagnetic braking system, providing added reassurance for adventures and exploration.
The 4mph manual-fold powered wheelchair has “exceptional performance”, Dash Rehab states. It can travel up to 12 miles on a charge, with 150W motors and a 12-amp lithium battery which is fitted inside a quick-release battery case for easy access.
The Dashi Lite has fixed armrests made from aerofoil foam and a swing-away leg rest, which offer users a safe and stable resting position. For a comfortable ride, the backrest is designed to fit the body curve, offering support for the lower back and helping muscles to stay more relaxed when seated for longer periods. The seat and backrest are crafted from a breathable fabric to aid relaxation.
For flexibility and ease of use, the chair’s intelligent operating system includes a clear display with USB port for smart phones, tablets, and aids. For extra peace of mind, day or night, the Dashi Lite also features LED headlights.
The Dashi Lite powerchair is compact and can be folded manually, making it easy to transport, with an overall lifting weight of 21kg, excluding the battery. It has a maximum user capacity of 100kg.
Brent McIvor, Sales and Marketing Director at Dash Rehab, said: “Delivering on performance and ergonomics, we genuinely believe the Dashi Lite is a highly functional yet practical solution for indoor and outdoor use.
“It is our entry-level model and as such is priced competitively. Users will appreciate the chair’s light weight and easy fold mechanism for transportation.”
Retailers wishing to know more about the Dashi Lite can contact Dash Rehab on 0845 146 0600 or email sales@rhealthcare.co.uk.
New data reveals that the NHS is missing out on procurements savings amounting to tens of millions of pounds.
In a report published today, the Public Accounts Committee (PAC) warns that NHS Supply Chain, which was created to save the NHS money through pooling hospitals’ purchasing power, has failed to persuade NHS trusts to use it to make billions in purchases.
The full report, ‘NHS Supply Chain and efficiencies in procurement: Twenty-Fourth Report of Session 2023–24’, can be read here.
NHS Supply Chain was created to solve the known problem that the NHS was not making the most of its collective buying power to get the lowest prices for its purchases.
PAC’s report finds that the organisation has so far failed to demonstrate that it is the answer the NHS needs. Of the £7.9 billion spent by NHS trusts on medical equipment and consumables, £3.4 billion is outside of NHS Supply Chain. This means that it is only achieving around 57 percent of market share to a target of 62 percent (a target revised down from an original 80 percent by 2023-24).
Trusts’ satisfaction with NHS Supply Chain is low and in steady decline (down to 54 percent in 2023-24 from a peak of 67 percent in 2021-22), according to the report. Over two-thirds of trusts say they shop elsewhere because of limited availability through NHS Supply Chain.
The report further raises concerns that a focus on costs may impact on the quality of outcomes for patients. The report, which finds that clinicians are not convinced that NHS England (NHSE) and NHS Supply Chain value quality over price, calls for clinicians to be involved in purchasing choices to ensure that better patient care is considered alongside value and cost.
David Stockdale, Chief Executive at BHTA, has underlined that the association and its members will continue to work alongside NHS Supply Chain to ensure procurement works for the whole of the medtech supply chain to ensure better patient outcomes.
“The BHTA and our members continue to be ready to work with NHS Supply Chain and the broader UK medtech supply chain to ensure procurement works for the whole of the supply chain, to ultimately deliver the patient outcomes we all want,” said David.
“We recognise the healthcare landscape is challenging for all parties currently and continue to believe that genuine engagement from all stakeholders will lead to the best outcomes.”
The report also questions the level of savings NHS Supply Chain reports it has made for the NHS. NHSE shared the organisation’s reported savings with it but using two different methods which generated two very different figures – £3.3 billion from 2016-17 to 2022-23, and £1.7 billion for the same period, risking confusion over how much NHS Supply Chain has actually saved. Trusts do not always recognise the savings that NHS Supply Chain reports, causing frustration and mistrust, PAC states.
PAC’s confidence in savings claimed by NHS Supply Chain is further undermined by the fact that the cumulative £3.3billion claimed has not been validated by either the UK Government or NHSE, with the organisation effectively marking its own homework.
Dame Meg Hillier MP, Chair of the Committee, said: “The problem NHS Supply Chain was created to address is well-established. Given the scale of the NHS’ collective billions of pounds worth of collective spend on procurement, ensuring the best value for money for the taxpayer is essential. But our report finds that trusts do not have the requisite confidence in NHS Supply Chain to utilise its services, leaving it at risk of being an answer to a question no-one is asking.
“Cost is of course only one factor when making high-stakes decisions around which equipment to use for patients, and it is essential that clinicians are given a seat at the table so that better patient care is considered alongside best value. All agree that high-quality equipment must be readily available to NHS trusts at the best possible price. The hard yards must now be put in to build trust in the systems that are there to deliver these outcomes.”
In response to PAC’s report, an NHS Supply Chain spokesperson stated: “We are committed to realising the full potential of NHS Supply Chain to deliver greater savings and efficiencies alongside a broader value proposition focussing on supply chain resilience, product safety, enabling access to innovation, social value, sustainability, and ethical considerations.
“We have redesigned NHS Supply Chain’s operating model and embarked on a major modernisation programme to upgrade key infrastructure and IT systems. We need to further improve and integrate our platforms to provide a more consistent experience for colleagues across the NHS and suppliers. As the NAO report highlighted our funding is managed on a year-by-year business cycle in line with NHS England’s business planning process.
“We are continuing to work together with the Department of Health and Social Care (DHSC), NHS England, NHS trusts, suppliers, and other system partners across the country to improve procurement in the NHS. This will be achieved through ongoing collaboration, partnership working and innovation.
“Over the last year we have been strengthening our engagement with our NHS partners to improve our understanding of their needs through our quarterly national and regional advisory forums, various panels and working groups. We are continuing to develop these engagement forums to ensure that they bring the voice of NHS colleagues and patients into the heart of our organisation. These engagement forums support our goals to make substantial improvements in satisfaction with our services by ensuring our business plans focus on those matters that will make the greatest difference to the NHS.
“NHS Supply Chain is clear that we can deliver over £1 billion of value by 2030. This can only be achieved by working in collaboration with all groups within the NHS, national bodies, industry associations, suppliers and NHS England. We have worked with NHS England and national representatives of the NHS trusts to develop a new standard saving methodology for the entire NHS and it’s expected that this method will be ready for all parties to use to calculate savings from April 2024. Our programme is aligned to this approach and reporting method.”
British Healthcare Trades Association (BHTA) member TGA, which supplies a wide range of mobility equipment, will be unveiling a new mobility scooter at Naidex 2024, the WHILL R.
This year’s Naidex takes place on 20 and 21 March at the NEC in Birmingham. TGA will be exhibiting on stand H110, where attendees will be able to get a first look at the new scooter.
The WHILL R is available in a smart scooter package with three- or four-wheel versions. It is designed to enable a diverse range of indoor and outdoor activities with a “fresh look”.
Inside, zero turn technology is a big plus, and outside, active suspension and high ground clearance mean stable driving over kerbs, grass, and gravel.
If owners use a car, then WHILL R quickly dismantles for the boot, and the lithium battery can be charged separately. Travelling by bus, train, or plane is equally as straightforward.
On arrival, there is10 miles of range with battery levels that are easy to see. The WHILL R further incorporates responsive controls and supportive seating.
Alongside launching WHILL R, TGA will also be demonstrating a selection of its established products on the stand, with new indoor and outdoor rollators. Scooters, powerchairs, wheelchairs, and wheelchair powerpacks will be available for test drives.
Visitors will also be able to try TGA’s new range of rise and recline chairs, Retreat and Retreat Plus. There will also be launching the latest walking aids range, including rollators Rollbuddy and Seata.
The UK Government has updated its guidance about the different classes of mobility scooters and powerchairs, with a new section describing what a “not in a class” vehicle is.
The guidance explains what class 2 and class 3 mobility scooters and powerchairs are. Usually, these devices are class 2 if it has a maximum speed of 4mph or less and class 3 if it has a maximum speed of 8mph.
The guidelines add: “The seller or manufacturer can usually tell you the class of your mobility scooter or powered wheelchair. If they cannot, you can check based on its speed, width and weight.”
Class 2 and 3 mobility scooters and powerchairs can be used on pavements, other pedestrian areas, and cycle tracks.
Class 3 mobility scooters and powerchairs can also be used on the road. These vehicles need to be registered with the Driver and Vehicle Licensing Agency (DVLA).
Now, the updated guidance underlines what “not in a class” mobility scooters and powerchairs are.
A not in a class mobility scooter or powerchair are those that can go more than 8mph, are wider than 0.85 metres, and weigh more than 150kg (or 200kg if any equipment is attached to them, like medical equipment).
Not in a class mobility vehicles can only be used on roads. Users must get a valid driving licence to drive one and register their vehicle with the DVLA.
Users may also need to insure their vehicle. More information about insuring or registering mobility scooters and powerchairs can be found here.
A new action plan has been published that outlines how NHS England will help to deliver on its commitment to small and medium enterprises (SMEs) and enable the NHS to benefit from their significant value and contribution to patient care.
The ‘Small and medium enterprises action plan’ states that NHS England needs to work together with other parts of the NHS to harness the expertise of SMEs through the SME Advisory Group. NHS England will use the SME Advisory Group to fundamentally change the way that the NHS does business with this vital sub-group of suppliers.
The SME Advisory Group was established by NHS England, the Department of Health and Social Care (DHSC), and NHS Supply Chain. This group advises NHS Commercial on issues affecting SMEs and their experiences with doing business with the NHS.
Its focus is on improving the opportunities for SMEs to engage with and compete for NHS business. The group has an advisory role and does not have decision-making responsibilities. It does not consider or discuss individual procurements or seek to influence current commercial opportunities.
The group consists of 12 SME businesses, spanning the sectors that the NHS buys from. View the full list of businesses involved in the group here.
As a result of working with the SME Advisory Group and other parts of the NHS, the action plan underlines that NHS England is committed to:
Each commitment is accompanied by information about why that commitment has been chosen, what NHS England will continue doing, and what NHS England will do by 2026 or earlier.
Beyond its own commitments, NHS England is also encouraging SMEs to do the following points to maximise the ability of the NHS to work in partnership with the NHS:
On stand D100 at Naidex 2024, British Healthcare Trades Association (BHTA) member Precision Rehab will be launching the Paravan PR30/II powerchair.
Precision Rehab is a UK supplier of bespoke powerchairs with over 30 years’ experience in the assessment, sales, servicing of specialist powerchairs.
The new Paravan PR30/II is a highly adaptable powerchair that can be fitted and modified with a wide range of additional equipment to meet the specific physical and medical requirements of the user. With a maximum user capacity of 140kg, which can be increased to 200kg, the device is suitable for most users.
The powerchair offers a tilt-in-space and lift function fitted as standard, which has a lilting height of up to 30cm. This means the user can engage with people at eye level when they are in an education, business, or social environment.
For increased comfort, the PR30/II has a contoured seat system with six different configurations of back and seat pads. It is controlled by an ergonomic joystick, which makes it easy to manoeuvre in confined spaces.
Matt James, Director and Founder of Precision Rehab, commented: “We are delighted to once again be attending Naidex and look forward to showcasing our range of powerchairs to visitors to the show. The event is a great opportunity to meet up with many of our existing customers from around the UK, many of whom have become friends over the years while also making new contacts.”
Precision Rehab will be exhibiting products by Paravan, New Live, Dietz, Eurovema, Mo-Vis and TrackMaster at this year’s Naidex. Matt and the team will be on hand to answer any questions, demonstrate the powerchairs on show, and book assessments.
The British Healthcare Trades Association (BHTA) is working in partnership with Trusted Assessing and Care Training (TACT) to launch a brand-new course designed for retailers of independent living equipment.
The ‘Trusted Assessors: Assessing in the Retail Environment‘ course is designed to accredit retailer members as Trusted Assessors.
BHTA represents over 400 organisations in the UK who are involved in the manufacturing, distributing, and retailing of healthcare and assistive technology products. It operates a Code of Practice to ensure high-quality service levels for the sector.
This new training-based programme enables customer-facing staff to learn the skills involved in assessing for suitable home adaptations equipment. The course was developed by TACT in consultation with the BHTA and its members, and it is accredited by OCN London.
David Stockdale, Chief Executive at BHTA, commented: “This programme underlines BHTA’s commitment to quality and raising standards in the sector.
“The Trusted Assessor model is known and in widespread practice in health, social care, and housing services across the UK. This initiative enables our retail members to be aligned with a best practice approach in assessing for equipment that in turn means they can be integrated into local pathways.
“Older and disabled people can expect to gain faster access to important solutions for their independence and be confident in the impartial advice provided.”
Retailers of equipment for independent living are experts in the product solutions they range, and this enables them to check suitability and tailor products to individual people’s needs. Many retailers are relied on in their local areas to visit people at home and demonstrate equipment to help people to live independently.
The Trusted Assessor model is based in occupational therapy models of practice and learning this approach enables an Assessor to evaluate the person and their environment in a systematic way to identify the best solution. Assessors are taught when to refer a case to an occupational therapist (OT), and this ensures best use of staff and resources whilst speeding up access to much-needed equipment.
“We’re delighted to be working with BHTA to provide this Trusted Assessor course to their members,” said Clare Barber, Director of TACT and an OT specialising in this field. “It’s a splendid example of how staff already visiting older and disabled people at home can be taught to carry out simple assessments for home adaptations with a best practice approach based on the Comptency Framework.
“Expanding the range of Assessors working in the UK by harnessing the skills of this specialist retail sector is an innovative way of speeding up access to much-needed equipment.”
The announcement of the new course follows several months of consultation with the BHTA and its members.
The course has also received positive feedback from TPG DisableAids, a mobility equipment retailer and a member of the BHTA.
Alastair Gibbs, the director of TPG DisableAids, commented: “For TPG DisableAids the Trusted Assessor scheme has been a real boost. We have various staff trained from Level 2 to Level 4 and it has given us some real credibility with a number of housing associations and local authorities. Those that were looking for a differentiator and an indicator of commitment to quality found it in our association to BHTA and Trusted Assessor.”
BHTA members can find out more by email TACT on info@trustedassessing.com or visiting the TACT website and completing an enquiry.
The British Healthcare Trades Association (BHTA) has recently welcomed Vanilla Blush as a new member. Vanilla Blush specialises in intimate healthcare apparel and devices for individuals who have undergone abdominal wall surgery.
The BHTA recently caught up with Nicola Dames, CEO of Vanilla Blush, to hear more about how the firm began, its unique products that combine fashion and healthcare while improving the lives of patients, and the tangible benefits of BHTA membership.
Nicola Dames, originally from Dublin, embarked on her journey toward nursing by leaving Ireland in 1998 to pursue a nursing course at Kingston University and St. George’s Hospital in Tooting, London. Before venturing into nursing, Nicola gained experience working in pharmacies across Dublin, where she served notable figures such as Fr. Ted and Lisa Stansfield.
Her career path took her to Brown Thomas, a prestigious department store, where she further honed her skills in customer service and retail. After qualifying as a nurse, Nicola discovered her passion for neurology, particularly within the realm of neuro-intensive care units (ITU).
However, her journey took an unexpected turn when she was diagnosed with ulcerative colitis. Despite this challenge, she found unwavering support in her now-husband, who accepted her illness without hesitation and proposed to her.
Following their marriage, Nicola and her husband, a secondary school teacher and fellow ITU nurse, made the bold decision to leave their jobs and embark on a new adventure in Spain.
Nicola commented: “After our time in Spain, my illness started to resurface, and despite medication, it became increasingly difficult to manage. Following two hospitalisations, the realisation dawned that I needed to be closer to home for better medical support. With my husband being Scottish, we made the decision to settle in Glasgow.
“In 2006, just one year into our marriage, I received the joyous news that I was pregnant. However, this happiness was short-lived as I was soon admitted to the hospital due to complications. Within a few weeks, I experienced the heart-breaking loss of both the baby and my large bowel. It was during this tumultuous time that I underwent surgery, resulting in the creation of a stoma (Ileostomy).”
Vanilla Blush was born out of this journey.
Vanilla Blush unfolds a compelling narrative rooted in Nicola’s transformative journey from nursing to fashion, coupled with her personal battle with ulcerative colitis. This distinctive fusion of healthcare and design expertise propels the creation of intimate health apparel and medical devices for individuals with stoma/ostomy or hernias post-surgery.
Noteworthy milestones, such as winning awards, launching medical devices, and delving into university-led research, underscore the company’s commitment to innovation and enhancing the lives of those who’ve undergone major surgeries.
The global reach, team expansion, and recent initiatives, like the launch of a new website, signify continued growth and impact. Furthermore, the emphasis on working collaboratively with all partners in the industry, making Vanilla Blush data-rich, adds a layer of sophistication to its narrative—highlighting a commitment to comprehensive industry engagement and knowledge.
Overall, it’s a story of resilience, purpose, and ongoing dedication to advancing healthcare solutions.
Discussing some of the challenges Vanilla Blush faces, Nicola commented: “As a small business deeply rooted in patient care, we understand the critical balance between clinical necessity and patient experience. In the dynamic landscape of cost-saving initiatives within the NHS, where decisions often hinge on distinguishing between luxury and clinical need, we proudly stand as innovators who prioritise both.
“Our garments, born out of empathy and expertise, are more than just products; they are solutions meticulously crafted to enhance patient well-being.
“While larger competitors may have the resources to reach decision-makers first, we advocate for a fair and inclusive evaluation of innovative solutions from small businesses. Our commitment to excellence isn’t measured by the size of our team, but by the impact of our patient-centric approach.
“We invite policy and regulation decisionmakers to recognise the unique value that smaller, innovative businesses bring to the healthcare landscape – a value that extends beyond the balance sheets to the very lives we aim to improve.”
Vanilla Blush decided to become a BHTA member for several compelling reasons, as Nicola explained: “First and foremost, our commitment to providing high-quality products and services aligned closely with the BHTA’s mission to promote excellence within the healthcare industry. We first heard about the BHTA through industry networks and recognised it as a reputable and influential organisation within the healthcare sector.”
Nicola added that by joining the association, Vanilla Blush gains access to a wealth of resources, expertise, and networking opportunities.
“This includes access to training and educational programs, regulatory guidance, and industry updates, all of which are invaluable for staying abreast of the latest developments and best practices in our field,” continued Nicola.
“Furthermore, being a member of the BHTA provides us with a platform to engage with other industry professionals, exchange ideas, and collaborate on initiatives that benefit the wider healthcare community. This not only enhances our visibility and credibility within the industry but also fosters partnerships and opportunities for growth.
“Specifically for our business, the BHTA can support us in various ways. This includes advocacy and representation on regulatory matters, ensuring that our interests are effectively represented at the policy level. Additionally, the association offers support with compliance and quality assurance, helping us to uphold the highest standards of product safety and efficacy.
“Moreover, being part of a larger association like the BHTA provides us with a sense of belonging to a community of like-minded professionals who share our commitment to excellence in healthcare. This collective strength enables us to amplify our voice, influence positive change, and drive innovation within the industry.
“In summary, our decision to become a BHTA member was driven by our shared values, the tangible benefits of membership, and the opportunities for collaboration and growth that it affords. We are confident that our partnership with the BHTA will not only support our business goals but also contribute to advancing healthcare standards and improving patient outcomes.”
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
The UK Government has launched its new Disability Action Plan, which outlines 32 steps it is taking to make the UK “the most accessible place in the world” for disabled people.
Some of the Disability Action Plan actions and pledges include publishing research into the accessibility of private sector products and services in spring 2024; a new working group to educate businesses on the legal rights of assistance dog owners and make it simpler to report when they are refused access to a business; and new research into emerging issues affecting disabled people in the UK over the next 20 years.
Minister for Disabled People, Health and Work, Mims Davies MP, said: “We are building on this government’s really strong track record of supporting and delivering for disabled people by using their key feedback to deliver vital, everyday changes to their lives and we have listened to their asks and are truly determined to deliver on them.
“This new wide ranging plan means disabled children can rightly enjoy the fun of the playground, disabled customers can use the services they’re entitled to and businesses who break laws around assistance dogs will be firmly held to account amongst other impactful changes.
“I look forward to seeing the immediate impact of the Disability Action Plan while we deliver on long-term reforms to make this country the most accessible and importantly equal place to live in the world – so everyone can live their lives to the full and thrive.”
The Disability Action Plan sits alongside the National Disability Strategy, which outlines the government’s long-term vision for transforming disabled people’s lives for the better.
Chair of the Disability Unit East Midlands Regional Stakeholder Network, Justin Donne, commented: “As a firm believer in inclusive and participatory decision-making, I have been honoured to witness the profound impact of the Disability Unit’s genuine engagement with disabled individuals and organisations during the consultation process.
“This collaborative approach not only amplifies the voices of those directly affected but also ensures that our policies and initiatives are truly reflective of diverse perspectives and needs.
“The invaluable insights shared have undoubtedly enriched our efforts towards creating a more accessible and equitable society for all.”
The Medicines and Healthcare products Regulatory Agency (MHRA) has designated two new UK Approved Bodies, delivering increased capacity for the certification of the performance and safety of medical devices.
LNE-GMED UK and Scarlet NB UK join the seven current UK Approved Bodies, increasing capacity for the certification of medical devices in the UK.
LNE-GMED UK has been designated as a UK Approved Body to assess and certify general medical devices in accordance with Part II of the UK Medical Devices Regulations 2002. Scarlet NB UK has been designated with a focus on assessing and certifying software and AI as a medical device (AI/SaMD).
This comes after two of the existing UK Approved Bodies had their scope expanded, with UL International UK now designated to assess and certify general medical devices (in addition to in-vitro devices), and TÜV SÜD now designated to assess and certify active implantables (in addition to general medical devices).
Before appointing an Approved Body, the MHRA conducts a detailed assessment process to ensure that organisations are stable and able to undertake impartial and objective conformity assessment activities; have an appropriate quality management system; and have the capacity and competence to undertake assessments and the processes they use meet the relevant regulatory requirements.
After successful designation, the MHRA monitors UK approved bodies’ activities including by regular audits and by witnessing some of their audits of manufacturers.
The BHTA Insurance Scheme – insurance expert Steve Aldridge explains how Verlingue can help you to ensure your business is properly protected.
Verlingue has provided BHTA members with an exclusive insurance scheme for 25 years. We have worked closely with BHTA to understand their Members’ diverse requirements and designed an Insurance Scheme to provide the protection the Members need.
In our first ‘Insurance Insights’ of 2024, our BHTA Insurance Scheme specialist, Steve Aldridge, outlines some features of the Scheme and explains why it provides such useful protection for members.
Over the next few months, we will be focussing on additional business services available as part of the Scheme.
Most importantly, the Insurance Scheme is exclusively available to BHTA Member companies.
As well as providing robust, comprehensive insurance cover, some of the key features include:
These insurances are automatically included without additional cost under the BHTA Members insurance scheme.
Yes. As part of the Insurance Scheme you will have exclusive access to a number of additional services. Examples of these include:
Over the next few months, we will provide more detail on each of these, but please feel free to contact me if you would like to find out more about them now.
First of all, it is an insurance service exclusively available to Members of BHTA.
Second, there is no cost or obligation to secure a quote. Even if the quote is not taken up, the process will result in a useful audit of the insurance arrangements highlighting gaps in cover or potential cost saving areas.
And third, it is a proven product providing bespoke, comprehensive insurance cover at a competitive price.
Members of the BHTA take great pride in ensuring their products are of the highest quality and will deliver exactly what clients need. The BHTA Members Insurance Scheme has been designed with the same values when it comes to delivering a high-quality product alongside excellent service.
If you would like to discuss how the BHTA Members Insurance Scheme can help your business, please contact Steve on 07557 264091 or email : Stephen.Aldridge@verlingue.co.uk.
Topro, a manufacturer of mobility products that help people regain their independence, has recently become a member of the British Healthcare Trades Association (BHTA). The company is best known for its high-quality rollators.
The BHTA recently caught up with Terence Clark, UK Country Director for Topro, to delve into Topro’s product offering, how joining the BHTA helps the firm to be more credible, and its future plans.
Terence joined Topro after considerable experience in the stairlift sector.
“Previously I worked for 10 years at Stannah Stairlifts as its local authority sales manager and before that for 24 years as Head of Sales at Clark and Partners, our own large dealership with multiple outlets and substantial sales into the public sector,” said Terence. “Both these companies would have been considered the best in field, and when I was considering leaving Stannah I knew I wanted to work for a company with similar values and levels of expertise.”
Always committing to the business he works for, Terence wanted a position at a smaller firm where he could have a larger impact. He saw the Topro job advertised in THIIS and called to have a chat.
“I found an instant rapport with the company and its aims,” he recalled. “The role at Topro is a good combination of the elements I liked in both previous roles/companies and allows me to use my strengths and my experience to good effect.”
Topro mobility products are manufactured in Norway. They are the “best in class”, according to Terence.
“Coming from Stannah, I knew that quality products are a huge part of the success of any organisation. We have also invested heavily in logistics, staffing, IT, and systems to equip the new Topro UK to compete at every level with new products in the pipeline to further complement our current ranges.”
Topro’s range of rollators include the new feature-rich indoor rollator Hestia, the indoor/outdoor hard-working Original, the multi-option 5G, the rugged Olympus ATR (All Terrian Rollator), and the attractive and advanced Pegasus carbon rollator.
In addition, there is the Neuro, which uses reverse logic braking to help clients with conditions like Parkinson’s to stay safe and active as long as possible. Lastly, the Forearm Walker2, one of Topro’s best-sellers, is a practical, lightweight, and stable forearm walker designed to provide great upper body support.
Terence added: “Taurus dealers have access to the Taurus range of walkers. With its growing use throughout the NHS and rehab centres, Taurus offers flexibility and stability, helping clients relearn to walk after surgery or other conditions where they may have become unstable or unsteady.
“The significant investment of the owners has meant that Topro competes at the highest standard on the world stage, and it was decided to look for a larger UK market share and a wider profile within the dealership network and the NHS. I was tasked with overhauling the whole UK business, and this is what has happened.”
Discussing overcoming challenges in the current business climate, Terence commented: “There are always challenges in business, and the impact of the cost-of-living crisis, coupled with various supply issues over past years, and of course Brexit and the changes that has created in legislation etc. are felt by all companies.
“We have a team committed to providing added value and an extremely well-regarded product offering working alongside the BHTA; we really are ready for the future.”
Becoming a BHTA member adds credibility to Topro.
Terence said: “I have been involved with the BHTA for decades and value its purposes, input, and advice.
“At Topro UK, I recognise that in order to be credible we need to connect with other manufacturers and dealers and gain depth of understanding of new and existing legislation and how this affects our world.
“We will be involved and a proactive part of BHTA. I look forward to integrating, meeting, and renewing friendships over the coming months.”
Topro will be attending several large exhibitions and conferences in 2024, including Naidex, the British Orthopaedic Conference, and the OT show.
Beyond this, Topro will be building on its reputation on the following five pillars, based on Terence’s knowledge of what is important to dealerships after 24 years as a mobility dealer:
To find out more about how the BHTA can support your business and how to become a BHTA member, visit this page.
A new report from the National Audit Office (NAO), the UK’s independent public spending watchdog, has revealed that the NHS is not making the most of its spending power to save money in purchasing medical equipment and consumables.
Entitled ‘NHS Supply Chain and efficiencies in procurement’, the report has found that the NHS has continued to spend more than £3 billion outside NHS Supply Chain, its purpose-built procurement route.
The NAO examined how effectively NHS Supply Chain is making efficiencies across NHS procurement and whether it has achieved its objectives of saving money and increasing its share of products (medical equipment and consumables) bought through it by the NHS.
For 2023-24, NHS Supply Chain estimates that annual NHS spending on products is around £8 billion.
At its inception in 2019, the Department of Health and Social Care (DHSC) set NHS Supply Chain a target to deliver £2.4 billion savings by 2023-24. As of 2022-23, it told the NAO that it had exceeded its £2.4 billion savings target – but although NHS Supply Chain reported progress against this target to NHS England (NHSE) on a quarterly basis, neither NHSE nor the DHSC has validated or checked these savings, the report underlines.
Importantly, the report states that NHS trusts spend approximately £3.4 billion outside of NHS Supply Chain’s function. Trusts are largely free to purchase goods outside Supply Chain, but in order to achieve its objective – to harness the NHS’s spending power – NHS Supply Chain needs to persuade them to use it to purchase goods.
There is a still lot of variation in the prices trusts pay. For example, for each hip replacement stem part purchased by the NHS in 2022-23, individual trusts paid up to £490, with a median price of £333. Supply Chain’s price for the same product was £258, which was the lowest price for that product.
In addition, the report outlines that customers’ overall levels of satisfaction with NHS Supply Chain are below target and in long-term decline. In its latest customer satisfaction survey, 71.8 percent of respondents noted that they use other supply routes because the products they wanted were not available through Supply Chain.
NAO further states that NHS Supply Chain needs to improve the performance of eDirect, a procurement route accounting for around £1.5 billion of orders via Supply Chain in 2022-23. Orders via this route were delivered on average 22 days late between June 2022 and March 2023.
Supply Chain recognises that its systems and processes do not work well for all its customers and that it needs to do more to become, and demonstrate that it is, the best-value option for NHS procurement. To do this, it needs to optimise prices for customers, make ordering as straightforward as possible, and deliver reliably on orders placed, the NAO suggests.
Gareth Davies, Head of the NAO, commented: “Delivering the right products for the NHS, on time and at the best available price is essential to make every pound count for patients. The NHS has enormous buying power, but it is not yet making the most of it.
“Supply Chain needs to do more to deliver, and to show that it is delivering, for the NHS. In response, trusts need to make use of the NHS’s buying power to secure the lower costs Supply Chain can bring, with support and clear direction from NHSE.”
In light of the report’s findings, the NAO recommends that NHSE should use its data on trusts’ spending to understand and challenge why trusts are not using NHS Supply Chain and incentivise and encourage greater use of NHS Supply Chain.
It also states that NHS Supply Chain should improve its understanding of why some customers are unsatisfied with its services and develop a targeted action plan to make substantial improvements in satisfaction.
Experts from the British Healthcare Trades Association (BHTA) First Aid Medical Equipment (FAME) Section have produced new guidance for guardians who are responsible for the maintenance and upkeep of public access defibrillators in their workplace or community to ensure they are “ready to rescue”.
Public access automated external defibrillators (AEDs) are gradually becoming more available, particularly after the UK Government initiative to have them in every school. However, many are not properly maintained, and, in an emergency, this could mean that they are rendered useless.
Most of the time, these AEDs sit waiting for the potential to save a life, but it is important to regularly check them so that they are ready to rescue when the moments matter.
For those able to purchase a public access AED for their area/club, it is important that a guardian(s) is assigned to keep the pads, devices, and cabinets in a condition that enables them to save a life if they are ever called upon.
The BHTA FAME Section felt that it was important to raise awareness of the ease of these weekly checks that will ensure that their devices are ready to rescue if ever required.
As part of the section’s strategy last year, they worked together to produce the new guidance document, titled ‘Is your defibrillator ready to rescue?’.
Read this helpful defibrillator guidance here, where there is also the option to download it as a PDF.
Foundations recently announced the winners of its National Healthy Housing Awards 2023, which celebrate the inspirational achievements of frontline staff, council teams, and charities in supporting people to live independently.
The awards, which took place on 5 December at the National Football Museum in Manchester, highlight the efforts of those working in the sector who ensure vulnerable and disabled people live in safe and accessible homes.
Recognising the invaluable contributions that housing occupational therapists make in the health, social care, and assistive technology sectors, the British Healthcare Trades Association (BHTA) sponsored this year’s Housing Occupational Therapist of the Year award.
Presenting the award at the event, David Stockdale, Chief Executive of the BHTA, said: “I’m delighted to be here on behalf of the British Healthcare Trades Association. We represent over 400 companies providing products and services for the health and social care sector.
“Our members know how critical it is to partner with you all to deliver the best possible outcomes that we can, so I’m delighted on behalf of our members to be sponsoring the Housing Occupational Therapist of the Year Award.”
The Housing Occupational Therapist of the Year award recognises the outstanding efforts of occupational therapists to enhance individual’s lives, overcome challenges, and contribute to the progress of the adaptations sector.
Neil Withnell, from Gloucestershire Health and Care NHS Foundation Trust, was crowned as Housing Occupational Therapist of the Year with two entries. Described as an asset to the team and having single-handedly accomplished many great outcomes in 2023, Neil’s dedication impressed the entire judging panel. His efforts have resulted in the fast-tracking of adaptations for many living with deteriorating conditions.
On winning the prestigious award, Neil commented: “I was proud to be nominated for Housing OT of the Year 2023, by two of the organisations I work for, earlier this year. I could not really believe that I had won in Manchester – it has taken a few days to sink in! I am humbled and delighted to be awarded this accolade especially considering the strength of my co nominees, who all work tirelessly to improve lives.
“I work as a Specialist Housing OT in a newly commissioned role to develop and redesign housing and adaptation services, as well as provide specialist advice and expertise on housing, disability and relevant legal issues in partnership with Gloucestershire Health and Care, NHS Gloucestershire ICB, district housing partners, clients and carers.
“I have worked on a number of projects over the last 18 months, including the development of a Trusted Assessor model for the Disabled Facility Grant (DFG) and adaptations processes with nine Band 4 assessors now in post, as well as the development of a new fast-track pathway for those with rapidly-deteriorating conditions. I also campaign for new build accessible housing to be included in local plans and review plans for district councils. We intend to implement an accessible housing register for social housing in Gloucestershire next year to ensure best use of the precious resource we have of adapted or accessible homes.
“I want to thank Foundations for a day of celebrations at the awards and the British Health Care Trades Association for sponsoring this important award – it really helps the sector, in the wider world of Health and Social care, to get this work recognised.”
The fourth year of the national Care Sector Supplier Awards took place in London this month, with the judges once again recognising the best providers of products and services to the care sector in the UK.
The Category Winners were announced at a lunch and ceremony on November 17 at the 5-star Royal Garden Hotel, Kensington, during an afternoon which proved to be a wonderful opportunity to get together some of the UK’s best suppliers to the care sector.
Twenty-eight companies made the shortlist for 2023, reflecting the increase in the number of entries and the growth in the number of companies entering this year.
The BHTA is pleased to have been an Association Partner to the Awards this year, where there was such a high standard of entry.
After carefully weighing up evidence of innovation, enterprise and performance across each year’s entries, the expert panel was able to highlight companies such as FaultFixers, Haigh Engineering and Beaucare Medical as top performers in their field.
Other examples of excellence include the Best for Therapies category being won by CareHomeLife, Best for Marketing, Creative and Information Services being scooped by PLMR Group, and the Award for Best for Personal Care going to Ontex.
A full list of the 2023 Results can be found here, and more detail on each winning entry is in the digital Winners Booklet, along with a photo gallery of the lunch and Awards Ceremony.
If the success of these companies has prompted you to consider putting your company forward for an Award, all of the details regarding entry and the relevant fees can be found on the Awards website. Entries open March 1, 2024.
The Care Sector Supplier Awards are now in their fourth year and are organised by the same team that runs the successful Care Home Awards, Home Care Awards and the new Retirement Living Awards. Their experience, built up over seven years, prompted the creation of the Care Sector Supplier Awards, purely aimed at recognising and rewarding suppliers of products and services to the care sector in the UK.
Verlingue UK is delighted to announce the renewal of the BHTA Insurance Scheme.
After a comprehensive review of the insurance market to ensure BHTA members continue to be provided with the very best insurance solutions, Verlingue is delighted to inform you that the scheme has been renewed with Markel. The Scheme provides competitive premium rates available in the market, along with access to exclusive and additional cover.
Verlingue has also negotiated enhanced Cyber Insurance cover, with the standard base cyber limit increasing from £25,000 to £50,000, and Cyber Risk Management being part of the insurance package, adding an extra layer of security for your business. It’s not just coverage; it’s a commitment to staying ahead in the ever-evolving world of cyber risks and risk management!
Lastly, as a member of the Scheme, you will still have exclusive access to the additional services that Verlingue has successfully arranged. Further details of these services and enquiries regarding the Scheme can be requested by contacting Steve Aldridge by email at Stephen.Aldridge@verlingue.co.uk
British Healthcare Trades Association (BHTA) member company Access BDD, a manufacturer of stairlifts and homelifts, has reported a “hugely” successful OT Show, engaging with many attending occupational therapists (OTs).
The working models of the HomeGlide straight stairlift and Flow X curved stairlift proved to be very popular with visitors to the stand over the two days, Access BDD says.
Both lifts meet the EN 81-40:2020 stairlift safety standard that came into effect in April this year. The show was a great opportunity for the Access BDD team to explain these new regulations and what they mean to qualified and student OTs, many of whom had little knowledge of this latest development within the stairlift industry.
“The OT Show was another great success for us as it enabled us to engage with a sometimes hard-to-reach audience and have some great conversations,” commented Andrew Musson, Access BDD Sales Manager for the UK.
“It’s more than just good to share; it’s about exchanging views, understanding needs, and exploring resolutions through responsible and innovative manufacturing.
“This event is vital for connecting with Occupational Therapists who are often involved in working with clients who are looking to invest in a stairlift and therefore have to navigate around the latest equipment and stay on top of the latest regulations.
“At The OT Show, we don’t just attend – we thrive in conversations that propel us forward.”
The HomeGlide stairlift is designed to meet all straight staircase requirements and comes with “luxurious” seat padding, armrest detection, and an emergency stop button as standard. This lift has a generous weight capacity of up to 160kg and can be installed on staircases as narrow as 740mm.
For added comfort, the Extra package is available with a powered swivel seat and linked footrest. For outdoor environments, the HomeGlide Outdoor package has a weatherproof coating to protect against rain, dust, and direct sunlight and has a weight capacity of 125kg.
The Flow X curved stairlift features Advanced Swivel and Levelling (ASL) technology, which enables the stairlift to rotate and swivel during travel, ensuring the stairlift is always in the safest and most comfortable position.
With ASL technology, the footrest remains independent from the drive unit and swivels with the seat, ensuring better posture and reduced knee bending.
The Flow X offers four rail options, including standard drop nose, vertical ‘short-start’ drop nose, horizontal overrun, and parking curve, meaning it can be installed on almost any staircase. It can support a maximum weight of 125kg and can fit on narrow staircases as small as 610mm. It has no visible mechanical parts.